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Abstract 
Background:  Heart Failure (HF) disease management programs (DMP) have shown to 
improve outcomes.  The aim of this heart failure pilot program is an evaluation program. 
Measurement of functional capacity utilized the Duke Activity Status Index (DASI) 
questionnaire. Since the DASI uses the patient’s ability to perform a set of common activities of 
daily living to gauge functional capacity based on the known metabolic cost of each activity in 
MET units, it is thought to be well suited for population studies in which assessment of 
functional capacity during follow-up is needed.   
Setting:    Rural Critical Access Hospital (CAH) with outpatient cardiology services. 
Methods:  This HF pilot is a program evaluation which involved a one group, pre-test 
and post-test design.  Five additional variables were analyzed to determine if any relationship 
occurred with O2 uptake change as noted in changes in DASI.  The five variables included key 
items for the pilot program: HF education, teach back method, inpatient nutrition consult, DC 
time out, and follow-up with a Nurse Practitioner (NP). 
Results:  There were a total of 17 patients who received the inpatient pilot program 
throughout their hospital stay until discharging home.  Eleven of the 17 patients benefitted from 
the entire program (inpatient & outpatient) with continued care in the outpatient cardiology 
department. Thirteen patients completed the inpatient and outpatient Duke Activity Status Index 
(DASI).  Paired T-Test was conducted to compare inpatient vs. outpatient of O2 uptake. There 
was no significant difference in scores for inpatient (M = 20.99, SD = 6.42) and outpatient (M = 
19.26, SD 5.28), t (12) = .94, p = .36 (two-tailed). Wilcoxson Signed Rank Test, non-parametric 
test of differences, demonstrated no statistical difference between inpatient and outpatient 
oxygen (O2) uptake; [z = -.839a, p =  .40].  An independent-samples t-test was conducted to 
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compare O2 uptake changes based on gender.  Difference between males’ and females’ ages was 
not statistically significant (p = .403; two-tailed).  Pearson correlation or Spearman correlation 
was used to give the direction and strength of the relationship between variables.  A moderate 
correlation was detected with age and O2 uptake change from outpatient vs inpatient, (p < 0.05).  
An independent-samples t-test was conducted to compare O2 uptake changes based on age.  
Average O2 uptake decreased by 7 for patients 70 or under (M = 7.00, SD = 4.82), and increases 
by 3 for those over 70 (M = 2.77, SD = 4.19); t (11) = 3.91, p = < 0.01.  Explanations for this 
inverse detection are multi-factorial.   
Five pilot program variables were analyzed to determine if any relationship occurred with 
O2 uptake change as noted in changes in DASI.  “Teach back method” demonstrated that two 
patients were unable (M = 7.5, SD = 5.16); 11 patients were able (M = -3.41, SD = 5.49); (t (11) 
= 2.60, p = .024 [two tailed]).  This is statistically higher at p < 0.05.  Especially surprising about 
this result is that average O2 uptake change of 7.5 for 2 patients who were “unable to teach 
back” is significantly higher, than average O2 uptake change of -3.4 for 11 patients who were 
“able to teach back”.  The scores of the 2 patients that “were unable” went up, while those that 
“were able”, went down on average.  
Conclusion:  The usefulness for clinical decision making regarding lower O2 uptake 
scores for those under 70 compared those over 70 cannot be fully described or understood given 
the nature of this result.  The fact that other clinical factors are also independent predictors of 
functional capacity indicates that an uncomplicated course of inpatient heart failure designated 
care is not, in of itself, sufficient to guarantee an optimal functional outcome.  This particular 
notion may also be apparent within the “teach-back” variable and O2 uptake change. 
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TRANSITIONS HOME FOR PATIENTS WITH HEART FAILURE:  A PILOT PROGRAM 
AT A CRITICAL ACCESS HOSPITAL 
Problem Identification 
Hospitals and health care systems are focusing on improving performance and patient 
outcomes in cardiovascular services, with a particular focus on heart failure (HF).  There is great 
interest in which aspects of HF management can prevent readmissions, decrease the cost per 
case, and improve the quality and satisfaction for this particular patient population (Hines, Yu, & 
Randall, 2010).  The June 2007 and 2008 Medicare Payment Advisory Commission (MedPAC) 
Reports to Congress highlighted avoidable re-hospitalizations as an area of high cost and low 
quality (Boutwell, Jencks, Nielsen, & Rutherford, 2009, p. 2).  According to Boutwell, Jencks 
and colleagues (2009), these reports have prompted leaders of health care systems across the 
country to begin to focus on avoidable re-hospitalizations in anticipation of potential changes in 
the healthcare market. 
In a rural 25 bed Critical Access Hospital (CAH), quality data for fiscal year 2005 
demonstrated that the CAH provided recommended HF care 79% of the time (Massachusetts 
Health Care Quality and Cost Information, 2006).  The recommended care is a nationally 
recognized set of measures known as “Core Measures” (Joint Commission [JC], 2010), or 
guidelines, which identify the treatments a HF patient should receive (Massachusetts Health Care 
Quality and Cost Information, 2006).   More recent data, however, demonstrates improvement in 
appropriate care with results fluctuating between 81% - 100% (Figure 1 & 2).  Specific 
performance concerns at this CAH regarding HF appropriate care reside specifically within 
smoking cessation and discharge instruction measurements (Figure 1 & 4).   
Statement of Problem. 
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Issel’s (2004) model for problem definition was used to construct the problem statement. 
The problem is stated as:  Increased frequency of hospital readmissions among adult patients, > 
18 yrs. of age, with exacerbation of known heart failure condition; as indicated by increased 
number of "same or similar" coded hospital admissions for same patients.  These re-
hospitalizations are related to de-compensating physiological processes, given existing 
vulnerable health, co-morbidities, and specific health practices.  It is assumed that the re-
hospitalizations are influenced by a lack of adequate primary care clinician teaching and regular 
follow up regarding disease management / prevention and the patients' own health behaviors. 
Avoiding HF re-hospitalizations requires identification and mitigation of barriers to 
system-wide improvement, and coordination across the continuum of care (Institute for 
Healthcare Improvement [IHI], n.d.).  On May 1, 2009,  IHI launched STate Action on Avoidable 
Re-hospitalizations (STAAR) a multi-state, multi-stakeholder approach aimed to improve the 
delivery of effective HF care at a regional scale (IHI, n.d.).  Other IHI initiatives to improve 
transitions and reduce readmissions includes Improving Transitions in Care Collaborative which 
focuses on creating an ideal transition for patients from the hospital to home with an aim to 
reduce 30-day readmission rates by 30 percent and increase patient and family satisfaction with 
optimal transitions and coordination of care (IHI, n.d.).  This Critical Access Hospital 30-day all-
cause HF readmission rate for 2010 is 11.76%, up from 2.38% in 2009 (Figure 3).   
The Centers for Medicare & Medicaid Services (CMS) included a Care Transitions focus 
in its 9th Statement of Work, which started in 2008.  As a result, Quality Improvement 
Organizations (QIOs) in 14 communities are now working to coordinate care and improve 
transitions with the specific aim of reducing re-hospitalizations (Boutwell, Jencks et al., 2009).  
Although there is currently no nationally adopted re-hospitalization measure, Boutwell, Jencks 
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and colleagues suggest that a number of states are preparing to publicly report 30-day re-
hospitalization rates. 
Evidence of Problem. 
As previously stated, the hospital current 30-day all-cause HF readmission rate is 
11.76%, a notable increase of over 9% since 2009.  Success in improving transitions of care and 
reducing avoidable re-hospitalizations requires engaging clinicians and providers across the 
organization and service delivery types (Boutwell, Jencks et al., 2009).  Reducing re-
hospitalizations in a state or region will require coordinated effort among providers and 
organizations that lack financial and perhaps information-sharing relationships. Finally, the 
participation and engagement of patients and families is essential to improving coordination of 
care and accessing care at the right time, in the right place, that serves the needs of the individual 
(Boutwell, Jencks et al., 2009).  
Results of Needs Assessment.   
In a more narrowly defined, traditional sense, a needs assessment is the means by which 
one determines the gaps, lacks, and wants relative to a defined population and a defined, specific 
health problem (Issel, 2004, p. 121).  The gap at the Critical Access Hospital (CAH) consists of a 
lack of a formal HF inpatient and outpatient program.  Another hospital affiliate has a formal 
inpatient and outpatient HF program; yet it may be difficult for patients to access their outpatient 
program based on location and distance.  Estimated mileage from the CAH to the affiliate 
hospital is approximately 21.8 miles; minimum of 38 minutes due to traffic.  This estimate does 
not include areas south from the CAH.  Furthermore, a majority of patients seeking HF care at 
the CAH are greater than 60 years old and have Medicare as their primary insurance; driving 
21.8 miles north, or more, may be a difficult and daunting endeavor for this population group. 
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Prior to the start of the pilot project, every HF patient at the CAH received a HF 
education packet which included a HF book describing key factors in living with HF and 
symptom management.  However, there was no system in place to document patient or caregiver 
understanding based on the education packet.  Given the fluctuation in outcome measures for HF 
discharge instructions, opportunities for improvement existed in closing various gaps by ensuring 
all HF patients receive adequate and appropriate education and discharge instructions by a 
designated HF nurse.  
Evidence of Stakeholder Support and Letter of Agreement 
Critical Access Hospital (CAH).  The primary stakeholders and/or key persons for this 
HF pilot program are based at the CAH and included the following:  Vice President (VP) of 
Operations/Chief Nursing Officer (CNO); Chief of Medical Staff; Executive VP/Chief Financial 
Officer (CFO); Chairman of the Hospitalist Program;  Medical Director of the Quality 
Management Department along with quality staff members; two Cardiologist’s and NP in the 
outpatient Cardiology Department; outpatient Cardiology Department staff; Cardio-Pulmonary 
Registered Nurse who served as the program assistant to the program facilitator for this HF pilot; 
HF Nurses from Med-Surgical Unit (2MS) and CCU (total of 24 HF nurses); Case Management 
Department; and the Dietary Department. 
Affiliate Hospital.  Nurse Practitioner in the Cardiology Department located north of the 
CAH agreed to participate in this project by capturing HF patients who lived near the CAH by 
administering the pilot program while inpatient and then scheduling the same patient for 
outpatient cardiology services at the CAH.  
Evidence of Agreement.  On file with CEO/CNO at the CAH and at UMass, Amherst 
doctoral nursing faculty.  The support of all these stakeholders was invaluable during the course 
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of this HF pilot.  Each person and department listed proved to be instrumental to the overall 
success of this HF pilot project. 
Evidence of the problem demonstrated in the literature.   
According to Chan and colleagues (2008) disease management programs aim to address 
the barriers to successful treatment by patient education and multidisciplinary coordination.  
Poor discharge processes, lack of timely follow-up, uncertainty regarding self-management 
tasks, and confusions about medications all result in highly variable care at times of transitions 
and  impact a large proportion of HF patients (Boutwell, Jencks et al., 2009).   
Goals / Objectives. 
  This CAH HF Pilot Program will focus on patient education, assessment of 
understanding HF disease management, and follow-up through a multidisciplinary approach to 
coordination of care.  This pilot includes designated HF nurses, Hospitalists involvement, post 
discharge phone follow-up by the program facilitator or program assistant, and outpatient 
intervention by an experienced Cardiology Nurse Practitioner.  The goal was to implement this 
pilot with all HF admissions during the pilot timeframe of January 1, 2011 through March 31, 
2011. 
The overall long term outcome measures of success with the HF pilot program focused 
on readmission rates and mortality (Taylor, Bestall, Cotter, Falshaw, & Hood et al., 2009).  
Specific pilot program outcome measures are described under Program Goals for Specific 
Outcome Indicators: Table II – V of this paper. 
Review of Literature 
Heart Failure (HF) affects nearly six million people in the United States, with about 
670,000 people being diagnosed with it each year (Centers for Disease Control and Prevention 
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[CDC], 2010).  In 2010, HF will cost the United States 39 billion dollars which includes the cost 
of health care services, medications, and lost productivity (CDC, 2010).  Hospitals and health 
care systems are focusing on improving performance and patient outcomes in cardiovascular 
services, with a particular focus on how the management of HF can prevent readmissions, 
decrease the cost per case, and improve the quality and satisfaction for this particular patient 
population (Hines, Yu, & Randall, 2010). 
Heart Failure is a complicated disease which requires lifestyle modifications involving 
complex medication regimens, ensuring adequate exercise and dietary discretion, and keeping a 
close eye on daily weights (White, Howie-Esquivel, & Caldwell, 2010).  The majority of HF 
care is performed at home by the patient and family or caregiver, however if these individuals do 
not know what is required, fail to see its importance, or face barriers to engagement in self-care, 
they will not participate effectively (Lindenfeld, Albert, Boehmer, Collins, Ezekowitz et al., 
2010).  While this concept is understood among healthcare providers, there is evidence 
suggesting that patients themselves remain unclear about their role in managing this disease 
(White et al., 2010; Chan, Heidenreich, Weinstein, & Fonarow, 2008).   
 A recent study by Jencks, Williams, and Coleman (2009) investigated Medicare claims 
data from 2003-2004 in order to describe the patterns of re-hospitalizations and characteristics of 
hospitals.  In the case of 50.2% of the patients who were re-hospitalized within 30 days after a 
medical discharge to the community, there was no bill for a visit to a primary care or specialty 
physician’s office between the time of discharge and re-hospitalization (Jencks et al., 2009).   
Conducting a literature review to evaluate evidence regarding intervention strategies in 
HF and disease management may provide meaningful evidence leading to specific changes in HF 
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interventions prior to discharging patients from the hospital to home; thus, reducing future 
readmissions (Willey, in press). 
A comprehensive search of the literature for HF and disease management evidence 
included the following databases: PubMed of the National Library of Medicine, Cochrane, and 
Cumulative Index of Nursing and Allied Health Literature [CINAHL].  The following MeSH 
terms were used for the PubMed search: “heart failure” (HF) and “disease management” (DM) 
and “randomize [publication type]”; however, the third term was alternated in PubMed to include 
an additional MeSH search term, “meta-analysis”.  The Cochrane search terms for the MeSH 
descriptor included: “heart failure” exploding all trees with qualifier “Nursing”.  Additionally, 
the Cochrane Database of Systematic Reviews listed 18 studies for HF.  The following terms 
used in CINAHL included: “heart failure” and “disease management” with third terms 
alternating from randomized controlled trials, meta-analysis, and prospective randomized study.  
Disease management (DM) is defined within PubMed MeSH term as a broad approach to 
appropriate coordination of the entire disease treatment process that often involves shifting away 
from more expensive inpatient and acute care to areas such as preventive medicine, patient 
counseling and education, and outpatient care (Woodward, 1995).  This concept includes 
implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome 
of a particular disease. 
Seventy-two articles were retrieved from the search of the above databases using the 
selected MeSH terms and accessing the Cochrane Database of Systematic Reviews.  Inclusion 
criteria consisted of full-text articles published in the English language.  Due to the rapidly 
changing evidence in HF research, studies were identified only from the last 6 years (2005 - 
2010).  Of these, one was a duplicate, one was non-English, one was expert opinion regarding a 
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previous RCT study, numerous studies combined HF interventions with other disease states, one 
study displayed conflicts of interest, two studies were on-going with pending results, two studies 
failed to include sample size and/or statistical results, one study focused on public policy, and 
one study demonstrated questionable inclusion criteria.  Also excluded were two studies which 
duplicated one another without focusing on specific HF interventions, one study was descriptive 
with 13 subjects from a parent RCT study; and seventeen were conducted prior to 2005.  In 
summary, of 72 articles, 53 had to be eliminated leaving 19 studies to be examined (See 
Appendix A).  Discussion of studies follows herein. 
Telephonic Monitoring and Telephone Interventions 
Copeland and colleagues (2010) assessed the effects of a telephone intervention which 
included access to a nurse advice line for symptoms and counseling 24 hours a day 7 days per 
week, medication compliance reminders, fluid weight management, diet, scheduled nurse 
education, vital signs monitoring, early treatment for escalating symptoms, along with faxed 
alerts being sent to the participant’s physician about signs and symptoms of decompensation.  
Results demonstrated modest improvement in weight monitoring and physical well-being with 
higher total costs of care, but no survival benefit.  However, the intervention may have prompted 
needed medical service utilization by facilitating access to care, resulting in higher costs of care, 
including outpatient and HF related care costs.   
Findings from the randomized, intent-to-treat design conducted by Esposito and fellow 
investigators (2008) in a population-based program providing primarily telephonic patient 
education and monitoring services showed virtually no overall impact on hospital or emergency 
room use, quality of care, or prescription drug use for the 33,000 enrollees.  However, for 
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beneficiaries with HF who resided in high-cost South Florida counties, the program reduced 
Medicare expenditures by 9.6 percent. 
 Ramachandran and fellow researchers (2007) demonstrated significant improvement with 
telephonic helpline access along with regular telephone calls reinforcing HF information and 
modification of drug dosages.  Results demonstrated improvements in functional capacity 
measured by the 6-minute walk test (p <0.05), drug therapy with beta-blockers (p <0.05), and a 
larger number of patients improved in NYHA functional class (p <0.004).  There were no 
significant differences in the number of emergency room visits or admissions in either group.  
Furthermore, these researchers suggest that their results may be due to cultural conditioning in 
the setting of a developing country which may not work in other geographical areas and may 
need to be adapted to local environments.   
 Riegel and colleagues (2006) tested the effectiveness of telephone case management in 
decreasing hospitalizations and improving health-related quality of life (HRQL) and depression 
in Hispanics of Mexican origin with HF.  While HF DM may be effective in other population 
groups, findings from this study suggest that a different approach may be needed in Hispanics 
since no statistical differences were found in HF readmission rates, HF days in the hospital, HF 
cost of care, all-cause hospitalizations or cost, mortality, HRQL, or depression.   
A literature review which was located outside of the mesh term search yet is worthy of 
inclusion since the primary purpose was to examine advanced practice nurse (APN) directed 
versus registered nurse (RN) directed telemanagement programs for HF patients.  According to 
Delgado-Passler and McCaffrey (2006)  research findings from three RCTs confirm establishing 
the APN role as an effective approach since APNs are able to change medication and dosages, 
order outpatient testing, and were better educated in the pathophysiology of HF; thus, reducing 
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frequent hospitalizations.  Outcomes from all three RCTs demonstrated statistically significant 
results in re-hospitalization rates with APN directed telemanagement care (p < 0.05). 
While the efficacy of structured telephone support or telemonitoring as a successful 
individual component of a HF program remains inconclusive as noted with various RCT findings 
included in this review, the systematic review conducted by Inglis and colleagues (2010) meta-
analyzed 25 peer-reviewed studies: 16 evaluated structured telephone support (5613 
participants), 11 evaluated telemonitoring (2710 participants), and two tested both interventions 
(included in counts).  Results demonstrated the following: telemonitoring reduced all-cause 
mortality (p < 0.0001) with structured telephone support demonstrating a non-significant positive 
effect (p = 0.08); all-cause hospitalization data revealed that structured telephone support was 
effective in reducing the risk of all-cause hospitalizations in patients with HF (p = 0.02), as was 
telemonitoring (p = 0.02); both structured telephone support (p < 0.0001) and telemonitoring (p 
= 0.008) reduced HF-related hospitalizations.   
This systematic review provides further confirmation of the efficacy of structured 
telephone support and telemonitoring interventions as an effective component of contemporary 
multidisciplinary HF management (Inglis et al., 2010).  However, Inglis and fellow researchers 
suggest that future use of structured telephone support and telemonitoring should be to use these 
interventions tailored to HF DM programs, population needs including geography of the 
population, available resources and most importantly, to patient preferences.  In addition, these 
researchers suggest that more work is required on the business models underlying the cost-
effectiveness of telemonitoring in particular.     
Implantable Hemodynamic Monitoring 
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The safety and efficacy of the use of an implantable hemodynamic monitor (IHM) 
management strategy to reduce the rate of heart failure related events (HFRE) in patients with 
diastolic heart failure (DHF) who were already receiving optimal medical care in a HF DM 
program, was analyzed by Zile and colleagues (2008).  Patients included in the DHF subgroup 
were previously described in the COMPASS-HF trial (Bourge et al., 2008) and had New York 
Heart Association (NYHA) Class III or IV HF, and were managed in a HF program with 
optimized standard medical therapy for at least 3 months before enrollment (Zile et al., 2008).   
Data presented in this subgroup of 70 DHF patients support the following conclusions: 
IHM was shown to be safe and was associated with a very low system-related and procedure-
related complication rate in DHF patients, and within the context of the limited power of this 
subgroup analysis, IHM-guided care did not result in a statistically significant reduction in HFRE 
rate or reduction in relative risk of a HFRE in DHF patients (Zile et al., 2008).  Similar finds 
were found in the COMPASS-HF study which demonstrated that the IHM guided care did not 
significantly reduce total HF-related events compared with optimal medical management 
(Bourge et al., 2008). 
Heart Failure Disease Management Programs 
Seven RCT studies evaluated the effectiveness of heart failure disease management (HF 
DM) programs with three studies evaluating the effectiveness of a nurse-led disease management 
program (Hebert et al., 2008; Jaarsma et al., 2008; Krantz et al., 2008).  Hebert and fellow 
researchers (2008) demonstrated better physical functioning throughout the 12-month nurse-
managed intervention, except for out-patient procedures, which were more costly in the nurse-
managed group.  This trial was conducted in an ethnically diverse, inner-city neighborhood and 
may not be generalized to other settings. 
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Jaarsma and colleagues (2008) demonstrated no benefit of a nurse-led management 
program 18 months after hospital discharge.  Findings demonstrated a slight increase in the 
number of short hospitalizations yet it is unclear how many of those patients were severely ill.  
Furthermore, it is unclear what the criteria for admission entailed, pointing to possible low 
thresholds for re-hospitalization. 
 Krantz and affiliates (2008) compared 6-month re-hospitalization rates among patients 
assigned to pre-discharge B-blockade coupled with post-discharge nurse management 
(intervention) versus usual care.  Results demonstrated at 6 months, B-blocker utilization was 
higher (p = < .001), mean NYHA class improved (p = .01), and total HF re-hospitalizations were 
reduced by 84% (p = .02), a trend toward improved LVEF was also observed.  This study 
suggests that pre-discharge B-blocker initiation coupled with nurse follow-up improves 
outcomes among HF patients with LV systolic dysfunction.  However, since these researchers 
used a hybrid treatment strategy combining both medication initiation and nurse follow-up, it is 
impossible to quantify the contribution of each program component to the observed improvement 
in outcomes.   
 The remaining four RCTs evaluated the effectiveness HF DM programs (Nguyen et al., 
2007; Del Sindaco et al., 2007; Nucifora et al., 2006; Ojeda et al., 2005).  Nguyen and fellow 
investigators (2007) assessed the long-term impact on the number of recurrent hospital 
admissions, ED visits, and mortality after a 6-month course in a HF DM program.  After a mean 
follow-up of 2.8 + 1.7 years, there was no difference in all-cause death, hospital admissions, and 
ED visits between those patients initially in the HF management program group and the controls.  
After multivariable adjustment, there was no difference in all-cause death alone between those 
initially assigned to the HF clinic and those receiving usual care.   
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 Del Sindaco and colleagues (2007) studied the long-term effects of a hybrid DMP 
involving cardiologists, primary care practitioner’s (PCPs) and nurses in older HF outpatients 
aged > 70.  Results demonstrated that the DMP was associated with a 42% relative risk reduction 
of an unplanned hospital admission due to HF, 25% fewer patients with at least one hospital 
admission for any reason, length of hospital stay for all causes or HF admission was significantly 
shorter in the DMP group (p = 0.0025), and a 36% reduction in all-cause death. 
 Nucifora and fellow researchers (2006) evaluated effects of a HF management program 
which included patient education, regular outpatient contact with a HF nurse, and outpatient 
visits with an internal medicine doctor planned at 15 days, 1 and 6 months after discharge.  
Results demonstrated no difference in the rate of symptom improvement, hospital readmissions, 
or hospital discharge to death between the intervention and control groups.  Additionally, 
unplanned outpatient visits were fewer in the intervention group (p < 0.001) with the mean 
number of unplanned outpatient visits per patient was 0.4 + 0.9 in the intervention group and 1.0 
+ 1.3 in the control group (p  < 0.001).  These results suggest that in order to reduce the number 
of hospital admissions for HF patients, a more intensive and long-term intervention may be 
needed than what was adopted in this HF management program study. 
 Ojeda and fellow investigators (2005) evaluated whether improvements obtained during 
an HF intervention program were maintained after an average period of 16 + 8 months when the 
intervention was stopped.  During the 16 + 8 month treatment period, patients in the intervention 
group had a lower rate of HF readmissions (17% vs. 51%, p < 0.01) and less all-cause mortality 
(13% vs. 27%, p= 0.03).  One year after stopping the intervention, there was no difference in HF 
readmissions (28% vs. 25%, p= 0.72) or all-cause mortality (14% vs. 17%, p= 0.64).  Thus, the 
positive effects of a HF program were clearly reduced when it was stopped. 
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 Two of the meta-analysis studies evaluated effects of Disease Management Programs 
(DMPs) on HF clinical outcomes (Gohler et al., 2006; Roccaforte et al., 2005).  Results 
demonstrated that DMPs have the potential to reduce morbidity, mortality, and hospitalizations 
in HF patients.  Both studies found a substantial reduction in the rates of all-cause hospital re-
admissions and HF-related hospitalizations.   
 Gohler and colleagues (2006) conducted a systematic literature search on RCTs 
investigating the effect of DMPs on HF outcomes and performed meta-analyses and meta-
regressions comparing DMPs and standard care for mortality and re-hospitalization.  Their meta-
analysis of 36 RCTs for a total of 8,341 patients yielded a statistically significant pooled 
differences in the following: first all-cause re-hospitalization of 8% (95% CI 5-11%, p < .0001), 
subsequent all-cause re-hospitalizations of 19% (95% CI 2-35%, p < .0001), and a statistically 
significant pooled mortality difference of 3% (95% CI 1-5%, p < .01);  all favoring DMPs over 
standard care. 
 Similarly, Roccaforte and fellow researchers (2005) conducted a systematic literature 
search on RCTs investigating the effect of DMPs on HF outcomes and performed meta-analyses.  
This study also explored whether specific types of DMPs, or different components, timing and 
duration of the program, were likely to be most beneficial.  Results from 33 RCTs demonstrated 
that mortality was significantly reduced by a DMP compared to usual care (p = 0.003), all-cause 
and HF-related hospitalization rates were also significantly reduced (p = 0.00001) respectively.  
In addition, different DMP approaches appeared to be equally effective as observed across 
several sensitivity analyses.  According to Roccaforte and colleagues, in high quality studies and 
programs lasting 3-6 months, findings were most consistently associated with a significant 
reduction in all outcomes considered.  These researchers concluded that a comprehensive DM 
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program for HF patients reduced mortality and hospitalizations and are potentially cost-saving in 
moderate to high risk populations.    
In contrast, the objective of Phillips and fellow researchers (2005) meta-regression 
analysis was to determine whether a hierarchy of effectiveness exists with respect to published 
protocols of HFDM incorporating specialist nurse-led HF clinics.  These researchers reviewed 
and deconstructed published protocols from randomized trials of HFDM with specialist nurse-led 
HF clinics.  Meta-regression analysis was conducted to study the relationship between 
differences in complexity of intervention and readmission rate, mortality, the combined endpoint 
of mortality and hospitalization, HF readmission, the number of hospital days utilized per patient 
during follow-up, quality of life (QOL), and cost of care.  They reported that complex programs 
that included hospital discharge planning and no delay in post-discharge clinic follow-up were 
the most successful showing a trend towards 70% relative reduction in risk for first readmission, 
two fewer hospital days utilized per patient per readmission (p = 0.02), and a 70% reduction in 
risk of HF readmission relative to usual care (p = 0.01).  Less complex programs did not impact 
readmission or hospital days utilized during follow-up relative to usual care. 
The systematic review conducted by Yu and colleagues (2006) indicated that DMPs are 
effective in ameliorating poor discharge outcomes.  The purpose of the systematic review was to 
identify the characteristics of DMPs which are crucial to reducing hospital readmission and/or 
mortality of hospitalized elderly HF patients.  Their results suggest that an effective DMP should 
be multi-faceted and consists of an in-hospital phase of care built into the DMP with care 
focused on intensive patient education, self-care supportive strategies, exercise, and psychosocial 
counseling along with developing a post-discharge plan to address the individualized risk factors 
of poor discharge outcomes.   
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Finally, the objective in the systematic review by Taylor and fellow researchers (2009) 
was to assess the effectiveness of DM interventions for patients with HF.  These researchers 
classified interventions from 16 trials involving 1,627 patients into three models: 
multidisciplinary interventions (a holistic approach bridging the gap between hospital admission 
and discharge home delivered by a team); case management interventions (intense monitoring of 
patients following discharge often involving telephone follow up and home visits); and clinic 
interventions (follow up in a HF clinic).  Conclusions from this review demonstrated the 
following: the single RCT of a multidisciplinary intervention showed reduced HF related 
readmissions in the short term with little evidence to support clinic based interventions; case 
management tended to be associated with reduced all cause mortality but these findings were not 
statistically significant (p = 0.23), although the evidence was stronger when analysis was limited 
to the better quality studies (p = 0.04), there was weak evidence that case management 
interventions may be associated with a reduction in admissions for HF and unclear what the 
effective components of the case management interventions are; no evidence of any benefit from 
clinic interventions due to the lack of sufficient evidence and statistical power.  The data 
abstracted from this review does not allow formulation of firm recommendations for practice.   
  This literature search revealed HF and DM MeSH terms resulted in several studies linked 
specifically to DMPs.  However, HF DM programs vary in their content as demonstrated in this 
review which is further supported within the American College of Cardiology and American 
Heart Association (ACC/AHA) Guidelines for the Diagnosis and Management of Heart Failure 
in Adults (Hunt et al., 2009).  Findings from the RCTs on HF DM do not allow one to draw 
strong conclusions about the benefits of various HF DM interventions because they were 
different in structure, content and intensity.  Several factors may have contributed to these 
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findings including sample size, intervention features vary from one DMP to another, usual care 
(the control group) was poorly defined and described or not described at all, and length of 
follow-up may not capture all long term effects.  In addition, according Gohler and colleagues 
(2006) due to the nature of DMPs, blinding of patients and care providers to the intervention is 
not possible.  Ultimately, that particular aspect may result in bias during a subjective assessment 
of outcomes (Melnyk & Fineout-Overholt, 2005). 
A systematic reviews or meta-analysis of available evidence regarding any problem or 
solution contains information representative of multiple studies distilled into a succinct summary 
derived from the synthesis of the evidence and authors include specific details that demonstrate 
the strength of the evidence with the strongest level of evidence graded as Level l.  Because 
Level 1 studies combines the samples of each study included in the review to create one larger 
study, the summary statistic is more precise than the individual findings from any one of the 
contributing RCT studies alone (Melnyk & Fineout-Overholt, 2005).  Results of this review from 
Level 1 evidence demonstrated positive benefits from heart failure disease management (HF 
DM) programs, structured telephone support, and telemonitoring interventions as an effective 
component of contemporary multidisciplinary HF management (Inglis et al., 2010; Gohler et al., 
2006; Yu et al., 2006; Roccaforte et al., 2005).   
Two meta-analyses (a meta-analysis is a form of retrospective research or investigation) 
demonstrated that DMPs reduced mortality and hospitalizations in HF patients (Gohler et al., 
2006; Roccaforte et al., 2005) with one meta-regression analysis suggesting that specialist nurse-
led HF clinics are a promising alternative and an appealing strategy for selected patients (Phillips 
et al., 2005).  Multidisciplinary care teams with an effective structure, using a wider range of 
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expertise, were found to be most effective in addressing the complex heath care needs of HF 
patients (Gohler et al., 2006). 
A widely accepted method and simple metric is The New York Heart Association 
(NYHA) classification system that grades heart failure I through IV, based on the extent of 
dyspnea and fatigue which is experienced and reported by the patient (Delgado-Passler & 
McCaffrey, 2006).  The majority of patients who have recurrent and frequent hospitalizations 
belong to either class III or class IV, yet without including this classification, it is difficult to 
gauge response to therapy (Lindenfeld et al., 2010).  According to Lindenfeld and colleagues, 
therapeutic recommendations often are directed toward patients within particular NYHA classes, 
thus functional capacity/activity level and severity of clinical disease should be evaluated and 
recorded based on the HYHA functional classification for all HF patients.  Success of therapy 
may be indicated by improvement of at least 1 functional class. 
Finally, another classification system developed in 2001 by the American College of 
Cardiology and the American Heart Association (ACC/AHA) Task Force on Practice Guidelines 
emphasized the classification of HF based on development and progression of the disease (Hunt 
et al., 2009).  They identified 4 stages involved in the development of the HF syndrome with the 
first two stages (A and B) not being HF, but are an attempt to help healthcare providers with the 
early identification of patients who are at risk for developing HF (Hunt et al., 2009).  Stage C 
denotes patients with current or past symptoms of HF (the bulk of patients with HF), and Stage D 
designates patients with truly refractory HF who may be eligible for specialized and advanced 
treatment strategies (Hunt et al., 2009).  This classification system, according to Hunt and 
colleagues (2009), is intended to complement but in no way replace the NYHA functional 
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classification, which primarily gauges the severity of symptoms in patients who are in Stage C or 
Stage D.   
Implications of the Evidence Review 
Findings from this critique demonstrated positive benefits from heart failure disease 
management (HFDM) programs, structured telephone support, and telemonitoring interventions 
as an effective component of contemporary multidisciplinary HF management (Inglis et al., 
2010; Gohler et al., 2006; Yu et al., 2006; Roccaforte et al., 2005), yet building a clinical case for 
HF programs requires cost monitoring and revenue analysis which are important in 
demonstrating the business case for HFDM programs and/or interventions (Hines, Yu & Randall, 
2010; Inglis et al., 2010).      
Heart Failure is a syndrome rather than a primary diagnosis with many potential 
etiologies, diverse clinical features, and numerous clinical subsets (Lindenfeld et al., 2010).  
This critique supports the notion that patients recently hospitalized for HF and other patients at 
high risk for HF decompensation should be considered for comprehensive HF DM and/or 
structured HF interventions including telephone support (Inglis et al., 2010; Gohler et al., 2006; 
Roccaforte et al., 2005).  Lindenfeld and colleagues (2010) describe high risk patients as those 
with renal insufficiency, low output states, diabetes, chronic obstructive pulmonary disease, 
persistent New York Heart Association (NYHA) class III or IV symptoms (Stage C or D HF), 
frequent hospitalization for any cause, multiple active co-morbidities, or a history of depression, 
cognitive impairment, inadequate social support, poor health literacy, or persistent nonadherence 
to therapeutic regimens.   
 Based on the evidence documented, recommendations are provided by this author which 
may aid in reducing re-hospitalizations and mortality in HF patients (Table I).  However, it must 
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be recognized that the evidence supporting recommendations is based on various population 
responses that may not always apply to every individual or specifically for this pilot program.  
Additionally, national guidelines can best serve as evidence-based recommendations for 
management, not as mandates for every patient (Lindenfeld et al., 2010).  
Table I.  Key Elements of a Heart Failure Disease Management Program  
Functional Capacity/Activity Level 
 
 
 
 
 
 
  
Development and progression of the disease 
Key Elements: 
• Evaluation and recording of functional 
capacity/activity level and severity of 
clinical disease based on the NYHA 
functional classification for all HF pts. 
during every admission or follow-up 
visit (Lindenfeld et al., 2010). 
• Evaluation and recording on 
development and progression of the 
disease: Stages A-D (Hunt et al., 2009).   
Disease Management 
 
Key Elements: 
 
• In-hospital phase of care built into the 
DMP with care focused on optimizing 
the patients’ clinical status, self-care 
supportive strategies, medication 
regimens, and on developing a post-
discharge plan to address the 
individualized risk factors of poor 
discharge outcomes (Yu et al., 2006).   
• Comprehensive education and 
counseling with patients and families 
prior to discharge from an acute care 
setting (Yu et al., 2006).   
• Consider screening for depression prior 
to discharge (Riegel et al., 2006). 
• No delay in post-discharge appointment 
with their PCP or clinic visit scheduled 
within 7-10 days post discharge 
(Phillips et al., 2005). 
• Continuation of post-discharge HF 
education during clinic follow-up (Hunt 
et al., 2009) 
• Consider structured telephone 
interventions (Inglis et al., 2010).     
• Consider telephone interventions for 
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medication counseling and review by 
an APN with prescriptive authority 
(Delgado-Passler & McCaffrey, 2006). 
• Consider a multidisciplinary care team 
as an effective structure in managing 
HF patients on an inpatient and 
outpatient basis (Lindenfeld et al., 
2010; Hunt et al., 2009; Gohler et al., 
2006). 
Key Performance Indicators Key Elements: 
• Consider outcome measures of a DMP 
focusing on readmission rates and 
mortality (Taylor et al., 2009). 
 
Cost / Benefit Monitoring Key Elements: 
• Conduct cost/benefit analysis in order 
to determine business case for in-
patient and out-patient HF program(s) 
(Hines et al., 2010; Inglis et al., 2010).   
 
To ensure high-quality and efficient care for HF patients, the consistent use of clinical 
practice guidelines developed by the American College of Cardiology (ACC), American Heart 
Association (AHA), and the Heart Failure Society of America (HFSA) should be promoted 
during and after hospitalization (Hunt et al., 2009; Lindenfeld et al., 2010).  The HFSA guideline 
incorporates elements and components for a HF DMP (Lindenfeld et al., 2010).  The 
recommended components include: comprehensive education and counseling individualized to 
patient needs; promotion of self care, including self-adjustment of diuretic therapy in appropriate 
patients (or with family member/caregiver assistance); emphasis on behavioral strategies to 
increase adherence; vigilant follow-up after hospital discharge or after periods of instability; 
optimization of medical therapy; increased access to providers; early attention to signs and 
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symptoms of fluid overload; and assistance with social and financial concerns (Lindenfeld et al., 
2010).   
In addition, a four-step process has been outlined by Hines and colleagues (2010) as a 
guideline for evaluating an organization’s current processes and developing new approaches to 
better manage the care of HF patients.  Strategies for reducing HF readmissions require 
significant analysis, planning, preparation, and appropriate execution in order to achieve positive 
outcomes (Hines et al., 2010; Yu et al., 2006).  According to Hines and fellow researchers (2010) 
new payment models are currently being proposed within the US healthcare system which 
creates a more compelling business case to manage post-acute care more effectively.  Given the 
significant volume of HF readmissions, as well as numerous potential policy changes focused on 
reducing costs, HF patients may benefit from hospital initiatives focusing on readmission 
reduction which is a key feature of the STAAR program. 
The STAAR program provides acute care centers in Massachusetts an opportunity to 
create an ideal transition home for HF patients.  This initiative is supported by the 
Commonwealth Fund with additional involvement and support from several organizations 
including: Institute for Healthcare Improvement (IHI), Massachusetts Hospital Association 
(MHA), Centers for Medicare and Medicaid Services (CMS), and Mass. Coalition for the 
Prevention of Medical Errors (Massachusetts Hospital Association, 2009).  Project leaders have 
signed on 20 hospitals to pilot the STAAR Initiative’s “Transitions Home Collaborative” with 
participating facilities located throughout the Commonwealth (Massachusetts Hospital 
Association, 2009).  The STAAR program provides acute care centers with an opportunity to 
reduce re-hospitalization rates by 30% with implementing various strategies which may result in 
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an increase of patient and family satisfaction with coordination and transitions in care 
(Massachusetts Hospital Association, 2009). 
Theoretical Basis for Change in Practice: Awareness-to-Adherence Model   
Clinical practice guidelines have been created for HF and disseminated by numerous 
authorities in the hope that clinicians will follow professionally advised prescriptions for best 
clinical practice; however, clinicians do not always follow the practices recommended.  The 
Awareness-to-Adherence Model was proposed by Pathman, Konrad, Freed, Freeman, and Koch 
(1996) is a framework for physician compliance which can be expanded and applied to 
additional providers such as nursing. 
Pathman and colleagues (1996) proposed that when clinicians comply with practice 
guidelines, they must first become aware of the guideline, then intellectually agree with them, 
then decide to adopt them in the care they provide, and then regularly adhere to them at 
appropriate times.  This model may prove useful in identifying ways to improve physicians’ 
and/or clinicians adherence to a variety of guidelines by demonstrating where they fall off the 
path to adherence.  Additionally, which are at greatest risk for not attaining each step in the path 
and factors associated with a greater likelihood of attaining each step toward guideline 
adherence.  A number of potentially important explanatory variables which did not appear in 
their analyses include physician and/or clinician use of performance feedback and use of prompts 
placed on charts by office staff to alert clinicians to guideline needs. 
The Heart Failure Society of America (HFSA) guideline incorporates elements and 
components for a HF DMP which includes strong evidence (Lindenfeld et al., 2010).  The 
Awareness-to-Adherence Model applied the HFSA guideline as a key reference source for the 
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program.  The HF pilot used this model to increase practitioner use of the guideline 
recommendations with HF patients during the acute care hospitalization and discharge process. 
Protocol and Program Tailoring for HF Pilot Program 
Project Design.  An evaluation design was chosen for the Capstone Project.  The HF 
Pilot Program (HFPP) was designed to evaluate the efficacy and impact of a multi-disciplinary, 
nurse managed Heart Failure Disease Management Program for patients admitted to the hospital 
for HF that was modified specifically for the Critical Access Hospital.  The design included pre-
test and post-test methods for the one group of patients seen during the HF Pilot Program which 
will be referred to throughout this paper as “HFPP” from this place forward.  
Sample.  Sample inclusion criteria limited sample selection to those patients admitted for 
HF who could be discharged home and then seen in the outpatient cardiology department for 
their follow-up appointment 7-10 days post discharge.  Prior to starting this pilot, it was 
determined that patients who would be discharged to an extended care facility or to another acute 
care facility will be excluded due to likelihood of loss to follow-up. 
Program Facilitator/Capstone Project Director.  The Critical Access Hospital (CAH) 
HF Pilot Program (HFPP) Facilitator and Director of the Capstone Project is a University of 
Massachusetts, Amherst, School of Nursing, Doctor of Nursing Practice candidate (DNPc) and 
Family Nurse Practitioner candidate (FNPc) student who is affiliated with this CAH and author 
of this project.   
Institutional Review Board (IRB) Approval / Exemption.  The HFPP Capstone Project 
was designed as an evaluation project which was presented to the Critical Access Hospital health 
system IRB and approved on December 22, 2010.  All patient information was protected 
according to hospital IRB policies as well as policies surrounding Health Insurance Portability 
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and Accountability Act (HIPPA) (U.S. Department of Health & Human Services [HHS], n.d.).  
Protection of data collection forms was maintained under double lock within the hospital and 
will be destroyed at the earliest opportunity unless these data collection forms are found to be 
pertinent for medical record justification.  
Discussion of Outcome Measures to be used in HF Pilot Program 
The HFPP outcomes for patients included patient satisfaction, readmission, mortality, and 
functional capacity of the HF patients. 
Patient Satisfaction.  A patient satisfaction survey was developed by the program 
facilitator and program assistant with submission of an amendment to the IRB for approval to 
administer with HFPP patients; acceptance received on January 3, 2011 (Figure 8).  All HF 
nurses were informed that this survey would be provided to all HF patients during their 
outpatient cardiology appointment as well as for those patients who may be lost to follow-up. 
These surveys were completed anonymously with no patient identifier being listed on the form.  
For those that were lost to follow-up, the survey was mailed to them asking to complete two 
sections: Inpatient and Overall, and asked to return via an enclosed postage paid envelope.  
Readmission.   The population impact variables for the patients were re-hospitalization 
rate and measurement of functional capacity.  Re-hospitalization rates are currently measured 
and reported by the CAH based on 30 day all-cause readmission rate (Figure 3).  Mortality will 
be discussed later in this paper under the Results, Data Analysis, and Interpretation section. 
Functional Capacity.   Functional capacity was obtained by a self-administered 
questionnaire known as The Duke Activity Status Index [DASI] (Hlatky, Boineau, 
Higginbotham, & Lee, Mark, Califf et al., 1989) (Figure 6).   The DASI was administered to 
each participant during their inpatient hospitalization period and after discharge during their 
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outpatient appointment within the Cardiology Department.  Additionally, it was determined that 
if a particular patient was being discharged to home and would be unable to follow-up in the 
outpatient program, the DASI would be administered 7-10 days post-discharge by the program 
assistant or the program facilitator via telephone contact.   This protocol change was approved by 
the Critical Access Hospital IRB. 
The DASI is a 12-item scale that assesses whether patients can perform a spectrum of 
activities without difficulty and provides insights into selected aspects of their perceived quality 
of life (Jaeger, Hlatky, Paul, & Gortner, 1994).  Therapeutic efficacy is usually assessed in 
clinical cardiovascular studies by measuring endpoints such as mortality or myocardial 
infarction; yet these “hard” endpoints do not provide a picture of the effect of medical care on 
the patient (Hlatky et al., 1989).  A reliable and valid measure of ongoing patient outcomes in 
terms of patient functional status would assess more subtle effects of therapy, and provide 
patients and clinicians with information relevant for therapeutic decision-making.  In addition, 
the DASI measures functional capacity in metabolic equivalents (METS) which is a useful and 
convenient way to describe the intensity of a variety of physical activities (Thompson, Gordon, 
& Pescatello, 2010).   
Defining physical activity, exercise, and physical fitness has been accomplished using 
several methods, including percentages of maximal oxygen consumption (VO2max), oxygen 
consumption reserve (VO2R), heart rate reserve (HRR), maximal heart rate (HRmax), or 
metabolic equivalents (METs) (Thompson et al., 2010).  Using METs allows values to be 
obtained for each intensity category provided across a range of functional capacities (Armstrong, 
Balady, Berry, Davis, Davy, & Davy et al., 2009).  One MET represents an individual’s energy 
expenditure while sitting quietly (Haskell, Lee, Pate, Powell, Blair, et al., 2007).  Further 
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defined, 1 MET = 3.5 mL-kg-1 –min-1 (Armstrong et al., 2009).  Light physical activity is 
defined as requiring <3 METs, moderate activities 3-6 METs, and vigorous activities >6 METs 
(Thompson et al., 2010).  Since the DASI uses the patient’s ability to perform a set of common 
activities of daily living to gauge functional capacity based on the known metabolic cost of each 
activity in MET units, it is thought to be well suited for population studies in which assessment 
of functional capacity during follow-up is needed (Ainsworth, Haskell, Leon, Jacobs, & Montoye 
et al., 1992; Hlatky et al., 1989).   
Furthermore, individualized modifications in treatment plans can be made based on a 
patient individual DASI scores comparing pre and post testing measures during their outpatient 
cardiology appointments.  From a physiologic function capacity standpoint, this data can provide 
clinicians an indication of whether or not the patient is improving physiologically enough to 
endure activities of daily living (ADL).  Without this data, the clinician will not know if a patient 
can perform certain ADL’s.  Results from the Women’s Ischemia Syndrome Evaluation (WISE) 
Study demonstrated usefullness of the DASI before exercise testing can risk stratify symptomatic 
patients and may improve identification of higher-risk, functionally impaired subjects that would 
benefit from pharmacologic stress imaging and targeted risk management (Shaw et al., 2006). 
Program Goals for Specific outcome indictors.  According to Issel (2004) goals are 
broad, encompassing statements about the outcome to be achieved, whereas objectives are 
specific statements about impacts to be achieved and are stated in measurable terms.   
The goals for this program were:  
Goal I:  All inpatient HF patients will benefit by the Critical Access Hospital HFPP. 
Goal II:  HF patients who are discharged home will have individualized discharge follow-up in 
the outpatient cardiology department at the Critical Access hospital. 
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Goal III:  HF patients who are seen in the outpatient cardiology department will have 
individualized care. 
Goal IV:  The overall pilot program and population effectiveness will be continually monitored. 
 The program team identified specific objectives for each program goal, with clear 
outcome measures for each of the objectives.  The program objectives, outcome measures and 
results are presented in Tables II-V.  Examples of Expected Outcome Results listed in the 
following Tables are discussed in detail in the Evaluation Section. 
Table II – Inpatient HF Pilot Program  
Goal:  All Inpatient HF patients will benefit by the Critical Access Hospital HF Pilot 
Program 
Objectives Outcome Measures Results 
Program Objective:  All 
identified HF patients will have 
a designated HF nurse caring for 
them while inpatient at the 
CAH. 
Program Outcome:  HF patients 
will have a designated HF nurse 
caring for them while inpatient 
90% of the time. 
Outcome Score = 100% 
While all pilot patients 
had a HF nurse caring for 
them during their inpatient 
stay (100%), mishaps 
occurred on the 
medical/surgical unit 
(2MS) on various day, 
evening, and night shifts 
with no designated HF 
nurse caring for the 
patient.  The med-surgical 
floor required frequent 
oversight due to repeat 
patterns of missed 
opportunities with 
protocol follow-through.  
Several of these missed 
opportunities pointed to no 
HF nurse working on a 
particular shift (scheduling 
issue) as well as HF nurses 
working yet not assigned 
to a HF pilot patient (see 
project limitations). 
Program Objective: An 
enhanced admission assessment 
will include identification of 
Program Outcome:  HF patients 
will have an enhanced admission 
assessment identifying 
Outcome Score = 100% 
All HF pilot patients had 
the caregiver identified 
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caregivers for D/C planning and 
predicting post-hospital needs. 
caregivers for D/C planning and 
predicting post-hospital needs 
90% of the time. 
during their inpatient stay.   
Population Objective:  HF 
patients and their designated 
caregivers will be provided with 
specific HF management 
instructions utilizing “teach 
back” techniques and “Ask me 
3” techniques specifically for 
provider teaching 
(National Patient Safety 
Foundation, n.d.)  
Population Outcome:  The 
patient and/or caregiver will 
verbalize understanding of HF 
disease management as 
demonstrated by “teaching 
back” the instructions to the HF 
nurse 90% of the time. 
 
Outcome Score = 88% 
Two HF patients and/or 
their caregivers were 
unable to verbalize 
understanding of HF 
disease management based 
upon the topic being 
taught.  While the “teach 
back” method was utilized 
with all HF patients and/or 
their caregivers during 
their inpatient stay, 
opportunities in 
documentation were noted 
by the program facilitator 
(addressed within the 
evaluation section of this 
manuscript). 
Program Objective:  Identified 
“new” HF patients will have a 
cardiology consult while 
inpatient.  This goal will allow 
“new” patients to be seen by the 
Cardiology NP and program 
facilitator on an outpatient basis. 
(“New” HF patients are defined 
as patients who have not been 
seen by the cardiology 
department at the CAH in the 
past). 
Program Outcome:  A 
cardiology consult will be 
ordered by the hospitalist for 
“new” HF patients who will be 
discharged home 90% of the 
time. 
Outcome Score = 100% 
All HF pilot patients had a 
cardiology consult while 
inpatient. Out of the 17 
patients who participated 
in the inpatient program, 
five patients were 
established patients within 
the cardiology department.  
The remaining patients 
were new patients or 
patients who were not 
seen for several years and 
considered new patients. 
Program and Population Dual 
Objective:  The DASI 
questionnaire will be provided 
to HF patients during inpatient 
status by the designated HF 
Nurse.  Inclusion criteria for the 
DASI are those patients who 
will be discharged home. 
Program and Population Dual 
Outcome:  HF patients who 
meet the inclusion criteria will 
receive and complete the DASI 
questionnaire 90% of the time 
during their inpatient stay. 
Outcome Score = 100% 
All identified HF pilot 
patients who meet the 
inclusion criteria 
completed the DASI 
questionnaire during their 
inpatient stay. 
Program and Population Dual 
Objective:   
HF patients will have 
Program and Population Dual 
Outcome:   
The “HF Discharge Time Out” 
Outcome Score = 82% 
While the Discharge Time 
Out document was utilized 
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“Discharge Time Out” to be 
completed by the discharging 
HF nurse. 
medical record form will be 
completed on HF patients 90% 
of the time. 
on all HF pilot patients, 
there were three patients 
in which the form was not 
fully completed. 
 
Table III – Transitions in Care 
Goal:  HF patients who are discharged home will have individualized discharge follow-up 
in the outpatient cardiology department at the Critical Access Hospital 
Objectives Outcome Measures Results 
Program and Population Dual 
Objective:   
Prior to inpatient discharge, an 
appointment and referral will be 
made to the outpatient 
cardiology department located 
at the CAH for HF patients to be 
seen 7-10 days post discharge. 
Program and Population Dual 
Outcome:   
HF patients will have an 
outpatient cardiology 
appointment within 7-10 days 
post discharge and be seen by 
the Cardiology NP, 90% of the 
time. 
Outcome Score = 65% 
Six patients were lost to 
follow-up and not seen in 
the outpatient cardiology 
department.  Patients lost 
to follow-up are addressed 
further within the 
evaluation section of this 
manuscript. 
Program and Population Dual 
Objective:   
HF patients will have a follow-
up phone call within 24-48 
hours post discharge. 
Program and Population Dual 
Outcome:   
HF patients will accept a 
follow-up phone call within 24-
48 hours post discharge 
conducted by the program 
facilitator or the program 
assistant 90% of the time. 
Outcome Score = 88% 
Follow-up phone calls 
were made to 15 patients 
post discharged: One 
patient died while inpatient 
with the second patient 
being discharged on a 
Friday returning for 
readmission on the 
following Monday 
requiring end of life care 
and hospice involvement. 
Minus the above two 
patients, this outcome 
score may be viewed as 
100% with two outliers. 
 
Table IV – Outpatient HF Pilot Program: To assess program effectiveness and impact on 
target population. 
Goal:  HF patients who are seen in the outpatient cardiology department will have 
individualized care. 
Objectives Outcome Measures Results 
Population Objective:  HF 
patients will be seen within 7-10 
days post discharge by the 
Cardiology NP and program 
facilitator. 
If NP is unavailable; pt’s will be 
Population Outcome:  HF 
patients will appear for their 
post-discharge out-patient 
appointment at CAH 90% of the 
time.  
Outcome Score = 91% 
Only one patient has 
rescheduled and will be 
seen the end of April. 
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seen by the covering 
Cardiologist if needed. 
Population Objective:  HF 
patients who were discharged 
from in-patient hospitalization 
and who do not show for their 
post-discharge appointment will 
be contacted by phone with 
specific follow-up questions and 
opportunities to reschedule their 
appointment.  To be conducted 
by the Cardiology NP and/or 
Program Facilitator 
Population Outcome:  HF 
patient who are not seen for their 
scheduled post-discharge 
appointment will respond to the 
call and set another appointment 
90% of the time. 
Outcome Score = 100% 
No show rate was 0% 
Only one patient has 
rescheduled their 
outpatient appointment.   
Program Objective:  The DASI 
questionnaire will be provided to 
HF patients who were 
discharged from inpatient status 
at the CAH during their 
outpatient appointment. 
Program Outcome:  DASI 
questionnaire will be completed 
by HF patients (who were 
recently discharged form 
inpatient status) during their 
outpatient appointment 90% of 
the time. 
Outcome Score = 76% 
We were unable to obtain 
post-discharge DASI on 
four patients: three deaths 
and one patient did not 
return our phone follow-
up call.  Out of 17 
patients who completed 
the inpatient program, we 
were able to obtain 13 
post discharge DASI’s via 
combination of follow-up 
appointment and follow-
up phone call. 
Population Objective:  Based 
upon the inpatient and outpatient 
interventions, HF patients METs 
score as calculated from answers 
on the DASI will demonstrate 
improvements. 
Population Outcome:  
Improvements of the METs 
score as calculated from answers 
on the DASI will be reported by 
HF patients 90% of the time. 
Outcome Score = 
See “Interpretation of 
DASI scores” under 
Evaluation section of this 
manuscript. 
Wilcoxson Signed Rank 
Test demonstrated no 
statistical difference 
between inpatient and 
outpatient oxygen (O2) 
uptake; z = -.839a 
Program Objective:  HF patients 
will receive an individualized 
treatment plan provided by the 
cardiology NP. 
Program Outcome:  
Documentation regarding the 
individualized plan is completed 
for all HF patients 90% of the 
time. 
Outcome Score = 100% 
The cardiology NP 
documented all 
individualized plans 
within each HF patients 
EMR 
Program Objective:  HF patients 
will receive additional teaching 
Program Outcome:  
Documentation regarding 
Outcome Score =100% 
All HF pilot patients 
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provided by the Cardiology NP 
and program facilitator 
education will be completed for 
all outpatient HF patients 90% of 
the time. 
received continued 
education by the NP and 
program facilitator. 
Population Objective:  HF 
patients and their designated 
caregivers will be provided with 
specific HF management 
instructions utilizing “teach 
back” techniques and “Ask me 
3” techniques specifically for 
provider teaching 
(National Patient Safety 
Foundation, n.d.) 
Population Outcome:  The 
patient and/or caregiver will 
verbalize understanding of HF 
disease management as 
demonstrated by “teaching back” 
the instructions the NP and the 
program facilitator. 
Outcome Score = 100% 
All HF pilot patients were 
able to teach back key 
components specific to 
HF management while 
home: weight monitoring, 
decreased sodium intake, 
and when to call NP with 
worsening symptoms. 
 
Table V –Evaluation of HF Pilot Program (Overall) 
Goal:  The overall pilot program and population effectiveness will be continually 
monitored. 
Objectives Outcome Measures Results 
Program and Population Dual 
Objective:   
Patient who meet the inclusion 
criteria for the HF Pilot Program 
(identified while inpatient and 
discharged home) will be 
included in the pilot both 
inpatient and outpatient.  
Program and Population Dual 
Outcome:   
Patient who meet the inclusion 
criteria for the HF Pilot 
Program (identified while 
inpatient and discharged home) 
will participate in the program 
to completion, 90% of the time. 
Outcome Score = 65% 
Eleven patients completed 
the entire program. 
Six patients were lost to 
follow-up in the outpatient 
cardiology department. 
 
Program and Population Dual 
Objective: 
Patients who have participated in 
the pilot program will be offered 
a satisfaction survey during their 
outpatient visit.  
 
Program and Population Dual 
Outcome:   
Patients who have participated 
in the pilot program will 
complete a satisfaction survey 
90% of the time. 
Outcome Score = 86% 
Twelve surveys were 
completed and returned 
out of 14 patients (3 
expired).  Patients were 
provided satisfaction 
survey’s during their 
outpatient appointments. 
Patient who were lost to 
follow-up were mailed a 
satisfaction survey with a 
stamped self addressed 
envelope to return back to 
the NP at the CAH (Tables 
XI-XIII). 
Program Objective:  
Dissemination of HF Pilot 
Program findings will be 
presented to all stakeholders in 
this proposal 
Program Outcome:  Ninety 
percent of Stakeholders will 
verbalize satisfaction of the 
pilot program results 
Outcome Score = Unable 
to determine. 
Dissemination of Findings 
scheduled at the CAH on 
Apr 28.  “Verbalizing” 
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satisfaction is not an 
appropriate measure; 
rather data regarding 
stakeholder satisfaction 
should be obtained by an 
anonymous survey similar 
to what was used with HF 
pilot patient satisfaction 
surveys. 
Program Objective:   The 
program facilitator will evaluate 
the program throughout Phase I. 
Program Outcome:  The 
program facilitator will be 
successful in evaluating this 
program via data collection 
during the entire Phase I process 
90% of the time. 
Outcome Score = 100% 
The program facilitator 
was successful in 
evaluating this program as 
noted within the 
manuscript. 
 
Specific Resource Program Outcome Indicators. 
  While the type and amount of resources required for a health program vary with the 
interventions to be used, the expertise of the personnel, characteristics of the target audience, and 
degree of attention paid to acquiring and managing resources all affect the success of a program 
(Issel, 2004).  Organizational inputs proposed for this HF Pilot Program include: Human 
resources, informational resources, monetary resources, physical resources, managerial 
resources, and time resources (Appendix B).  The organizational plan objectives serve as a guide 
as to which activities are the most critical for implementing a health program. 
  Service utilization inputs proposed for this HFPP include: Recipients, participants, 
queuing, social marketing, and interventions (Appendix C).  Before the HFPP can be delivered, 
people need to know about it; this is the purpose of social marketing (Issel, 2004).  Determining 
through the process of screening based on criteria, who will participate in the program is another 
aspect of the service utilization plan.  The intervention delivery takes the most effort, yet can be 
easily achieved if the planning has been well-developed.  Prior to full program implementation, it 
is best to pretest the program or “pilot” the program in order to analyze process components.   
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Cost / Benefit Analysis of the HF Pilot Program 
As noted in Figures 1, 2, and 3, opportunities for improvement at this CAH regarding HF 
care were clear; yet building a clinical case for HF programs requires cost monitoring and 
revenue analysis.  These are important in demonstrating the business case for HFDM programs 
and/or specific interventions (Hines, Yu & Randall, 2010; Inglis et al., 2010).  Estimated costs 
prior to implementation of this HF pilot program at this CAH are listed within the Proposed 
Inputs and Outputs to the Organizational HF Pilot Proposal (Appendix A) and the Proposed 
Inputs and Outputs to the Service Utilization Plan (Appendix B). 
Chan and fellow researchers (2008) determined various cost estimates for HF disease 
management programs which were standardized to 2005 US dollars by the consumer price index 
for health care (Figure 10).  In reviewing available data at this CAH for readmissions of HF 
patients within 30 days during fiscal year 2009 - 2010, it can be estimated that the total charges 
equaled $561,107.68 for 58 total readmissions with charges per case estimated to be $9,674.27 
(personal communication, T. Rinaldi, November 21, 2010).   However, understanding CAH 
designation is another aspect to consider when calculating a cost-benefit analysis.  Legislation 
enacted as part of the Balanced Budget Act (BBA) of 1997 authorized states to establish State 
Medicare Rural Hospital Flexibility Programs (Flex Program), under which certain facilities 
participating in Medicare can become CAH (Centers for Medicare & Medicaid Services [CMS], 
2008).  Medicare pays CAHs based on reported costs; each CAH receives 101 percent of its 
costs for outpatient, inpatient, laboratory and therapy services, as well as post-acute care in the 
hospital’s swing beds (Medpac, 2007).  CAHs are not subject to the Inpatient Prospective 
Payment Systems (IPPS) and Hospital Outpatient Prospective Payment System (OPPS); 
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Medicare pays CAHs for most inpatient and outpatient services to Medicare beneficiaries on the 
basis of reasonable cost (CMS, 2008).  
Additionally, benefits to the hospital in preventing readmissions are hard to calculate for 
many reasons.  For example, Centers for Medicare and Medicaid (CMS), Joint Commission (JC), 
and Blue Cross and Blue Shield (BCBS) provide incentive payments to CAH’s for all HF 
patients meeting specific HF core measure outcomes which are estimated to be approximately 
3.75% per admission (G. Ritter, personal communication, November 18, 2010).  However, the 
amount of these payments is not public information.  Therefore, a cost / benefit analysis for this 
CAH is an estimate due to the inability to clear figures on these monetary benefits.   
Finally, an important aspect to consider regarding cost-benefit involves doing what is 
right for patients.  For example, improvements in care may translate into avoidance of 
readmissions which ultimately impacts quality of life (QOL) for these patients.  Avoiding re-
hospitalization allows HF patients to live independently with their families and loved ones.  
Thus, monetary benefits regarding QOL are also difficult to calculate.  According to the United 
States National Library of Medicine and National Institutes of Health (n.d.) it is rarely possible 
or necessary to identify and quantify all costs and all benefits (or outcomes), and the units used 
to quantify these may differ.  It may be more appropriate to conduct a cost-effective analysis 
(CEA) which is a comparison of costs in monetary units with outcomes in quantitative non-
monetary units, e.g., reduced mortality or morbidity. However, crossing the imaginary line into 
rejection due to increased cost may not be the right approach (Figure 11).  The tradeoffs of costs 
and effectiveness require careful weighing with consideration to standards of care. 
Inpatient Heart Failure Pilot Program.  Attempts were made at the CAH in estimating 
cost / benefit of the inpatient heart failure pilot program and listed in Tables VI – VIII 
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Table VI.  – Estimated Costs for Inpatient HF Pilot Program 
Implemented for 
Pilot 
Cost per Patient Cost for Pilot  
N = 17 pts 
Annualized cost  
N = 56 pts 
Average hourly 
nursing rate of 
$31.25 
1. DASI: 5-8 
min. 
2. Education 
based on HF 
book: total 2 
hrs. 
3. DC time out: 
20 min. 
 
 
 
1. $5.21 
 
2. $62.5 
 
3. $10.42 
 
2.5 hrs per patient 
Total: $ 78.13 
 
 
Total cost for 
inpatient pilot based 
on 17 patients 
 
 
 
Total: $ 1,328 
 
 
Annualized cost for 
inpatient program 
based on 56 patients 
 
 
 
Total: $ 61,264 
(this is the cost of 
nurses which is built 
into their wages) 
 
Table VI estimates what nurses are doing for the HF pilot patient at the CAH. They are 
supporting the patient through the DASI, HF education book, and DC time out so that all 
components are completed.  For the nurse to accomplish and support this HF inpatient program 
during hospitalization equals 2.5 hrs per patient = $78.13 x 17 pt’s = $1,328; to annualize = 
$61,264. 
 Table VII demonstrates a breakdown on the readmissions during the pilot period.  
However, a detailed discussion regarding readmissions is described within the results section of 
this paper.  Readmissions were reviewed to determine if the readmit was related to a HF 
diagnosis.  While hospitals report HF readmission as 30-day all cause, readmissions for this pilot 
program revealed only one being related to a HF diagnosis with certainty; thus, 5.88% 
readmission rate was determined for the first quarter of this HFPP. 
Table VII – Breakdown on Reasons for Readmission within 30 days 
Patient Number 
N = 5 
Reason LOS for 
readmission 
Related to HF 
diagnosis? 
105 Dyspnea / overlying 
pleural effusion 
3 days Questionable 
108 Coreg 25 mg b.i.d. 
not tolerated 
1 day yes 
110 End of Life 3 days Questionable 
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requiring hospice 
112 Panic attack leading 
to SOB 
1 day Not directly 
115 Dyspnea / 
pneumonia 
9 days Not directly 
One patient out of 17 was readmitted due to heart failure diagnosis  =  5.88% readmit rate 
                                                                                                                   For 1st Q 2011 
 
 ANNUALIZED:   4 pt. in 2010 / 56 pts                                             =  7.14% readmit rate 
 
To annualize, refers to expressing a variable in yearly terms even though the variable 
does not directly apply to a year (Farlex Financial Dictionary, 2009).  That is, an annualized 
variable has been mathematically converted to yearly terms (Farlex Financial Dictionary, 2009). 
An annualized variable is often theoretical; there is no guarantee that the rate in the example 
above will be 7.14 % if it is calculated after a month or two.  
According to Ross and colleagues (2010) there has been no recent national or regional 
improvement in hospital readmission care among Medicare beneficiaries discharged after HF 
hospitalization. Recent national hospital-specific risk-standardized readmission rates approached 
25% for the most common discharge diagnosis among Medicare beneficiaries and the 
distribution in hospital performance has not shown beneficial changes. 
Table VIII – Benefit for Inpatient HF Pilot Program  
 Charges/case 2010 2011 Annualized 
Readmission per pt 
 
$9,766.16 loss $68,596.96 $39,064.64 
Assume Contract 
Reductions 
= 40% of charges 
received 
23,438.78 15,625.86 
   7, 812.92 
Loss / cost 
avoidance by 
decreasing 
readmissions 
 
A main benefit for this CAH and other hospitals resides in cost / loss avoidance.  Table 
VII reflects the DRG charge per patient which is not reflective of cost.  For every readmission, 
TRANSITIONS HOME FOR PATIENTS WITH HEART FAILURE  45 
the CAH will not be paid yet care will still be delivered.  Cost / loss avoidance is a benefit for all 
hospitals when they can successfully decrease hospital readmission rates. 
As previously stated, pay-for-performance models demonstrate financial incentives and 
public recognition for top-performing hospitals as well as financial penalties for hospitals that do 
not improve above a pre-defined quality measure thresholds (Premier, Inc., 2006).  These figures 
were not available from the CAH. 
Outpatient HF Pilot Program.  Attempts were made at the CAH to estimate the 
cost/benefit of the outpatient heart failure pilot program and listed in Table IX. 
Table IX. – Cost versus Benefit for Outpatient HF Pilot Program  
Variables Cost / Benefit 
$72.63 per Medicare payment x 15 pt’s $1,089.45 revenue for reimbursement 
$  0.    per two patients due to health insurance $   0 for reimbursement 
With 17 patients x 30 min appt’s = 510 min = 
8.5 hr of NP time 
8.5 hrs x 41.2 (average leadership salary range) 
= $350.2 cost 
 
Increased revenue with Medicare was noted within the outpatient HFPP as noted in Table 
IX.  Reimbursement received based upon 15 Medicare patients versus the cost of an NP (with 
average leadership salary range) demonstrates revenue of $739.25.  However, annualizing cost or 
reimbursement was not possible for the outpatient components of the program due to inability in 
obtaining clear figures surrounding monetary benefits.   
Finally, as a consequence of limited data regarding the cost-benefit of HF DMP’s in general, 
several aspects of HF cost of care remain poorly understood especially in the area of HF resource 
use in the outpatient setting (Liao et al., 2007).  Accountable Care Organizations (ACOs) are 
projected to become a new trend in health care with potential to create opportunities for rural 
health care providers to improve health care quality and control health care costs within their 
communities (MacKinney, Mueller, & McBride, 2010).  MacKinney and colleagues describe 
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these ACOs as payment and delivery system reforms to improve health care quality and control 
costs through care coordination and provider collaboration, with accountability for its 
performance. 
The ACO model has received significant attention among policymakers and leaders in the 
healthcare community in the context of the ongoing debate over health reform, not only because 
of the unsustainable path on which the country now finds itself but also because it directly 
focuses on what must be the key goal within our healthcare system: higher value (Lowell & 
Bertko, 2010).  This particular HF Pilot Model would fit into an ACO model of care in terms of 
care coordination and provider collaboration. 
Timeline of HF Pilot Program 
 Nov – Dec. 13, 2010; HF Pilot Proposal submitted with acceptance by doctoral 
committee members and the designated mentor for the project at the CAH.  Met 
with key stakeholders throughout this period.  Worked on developing necessary 
tools for data collection. 
 Dec. 13, 2010 – December 31, 2010; all necessary aspects were in place: 
Documentation tools, clinician roles, staff education, and IRB approval.  
Contacted biostatistics department at UMASS, Amherst for statistical consulting. 
 IRB approval granted December 22, 2010. 
 Phase I:  HF Pilot Program (HFPP) Implementation: Jan 1, 2011-March 31, 2011; 
Inpatient & Outpatient HF program in place.  
 April – April 30, 2011; Analysis of results:  
o Approx. 15 - 20 patients were initially estimated.  Actual patients equaled 
seventeen. 
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 April – May 01, 2011; written evaluation of program and dissemination of 
findings to UMASS, Amherst and the CAH.   
o Data analysis: Includes statistical analysis with assistance by a 
biostatistician at UMASS, Amherst and comparative qualitative analysis 
of findings by comparative review: case by case. 
 Phase II: Post Doctoral ~ Continuation of Program; CAH Senior Management 
determined feasibility for continuation of HF program for an additional three 
months, scheduled to end on June 30, 2011.  Adoption of program will be 
determined upon analysis of outcome measures.    
HF Pilot Program Development and Implementation 
In order to design an effective program for HF patients at the CAH, the program 
facilitator conducted an assessment of the “current state” of HF treatment in the setting.  Based 
on this assessment, the program facilitator developed the HFPP based on the recommendations 
from the Clinical Practice Guideline and best evidence. 
   Medication Reconciliation.  According to various officials at the CAH, the new 
electronic medication reconciliation process instituted during November 2010 was designed to 
alleviate medication fall-outs.  Medication reconciliation process at the CAH was projected to 
reach 100% compliance due to their recent electronic advancements within the electronic 
medical record and pharmacy division.  This recent advancement was expected to be beneficial 
during all patient admissions and during the discharge process.  Mechanisms were in progress 
outside of this pilot to track and monitor this process. 
Despite these efforts, two medication issues occurred during the HFPP with discharge 
medications, both regarding combivent (ipratropium bromide and albuterol sulfate) a known 
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bronchodilator.  These two problems impacted HF Core Measures.  The Quality management 
staff addressed these issues with various staff and council members at the CAH.  Opportunities 
for improvement in medication reconciliation exist including double checking/safety net 
mechanisms with another staff member to ensure all key items are in place prior to discharging a 
patient in order to avoid any additional medication discrepancies. 
Multidisciplinary care team with specialized HF nurses.  The evidence supports the use 
of a multidisciplinary care team as an effective structure in managing HF patients on an inpatient 
and outpatient basis (Lindenfeld et al., 2010; Hunt et al., 2009; Gohler et al., 2006).  In addition, 
an effective intervention to reduce hospitalizations encourages consistency of specially trained 
nurses in providing acute care for patients with chronic conditions such as HF (Boutwell, Griffin, 
Hwu, & Shannon, 2009).  While the CAH incorporates a multidisciplinary approach to patient 
care, they did not have designated specially trained HF nurses.   
Evidence supports the effectiveness of a designated trained HF nurse who works with the 
patient and family or caregiver during the hospitalization to conduct patient education, arrange 
post-acute follow-up, confirm medication reconciliation, and prepare them for discharge 
(Boutwell & Hwu, 2009).  The program facilitator provided pilot education to all the HF 
designated nurses to ensure they understood the pilot purpose along with various outcome 
measures for evaluation.  
Effective Teaching and Enhanced Learning.  According to Joint Commission (JC) 
(2010) HF patients or caregivers discharged home must be given written instructions or 
educational material. These materials must address all of the following: activity level, diet, 
discharge medications, follow-up appointment, weight monitoring, and what to do if symptoms 
worsen.  Prior to this pilot, the CAH provided HF patients and their families with an evidence-
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based HF education packet which describes simple pathophysiology of HF, along with dietary, 
activity, weight monitoring, and symptom monitoring within the booklet entitled: “A Stronger 
Pump: A guide for people with all types of Heart Failure” (Purcell & Fletcher, 2009).  In 
addition, the packet contains a stop light laminated sheet (8.5 x 11) describing signs and 
symptoms and what to do if they are in a green, yellow, or red zone.  This stop light is designed 
to guide patients and families in monitoring their status and providing guidance instructions for 
recommended follow-up.  However, there was no system in place to track patient or caregiver 
understanding of this packet.   
Lindenfield and fellow researchers (2010) have described the importance of adequate 
patient and family or caregiver teaching.  They report that inadequate education and counseling 
can lead to the following (p. e101):   
• Poor communication and coordination of care among health care providers. 
• Inadequate discharge planning. 
• Failure to organize adequate follow-up care. 
• Clinician failure to emphasize non-pharmacologic aspects of HF care, such as 
dietary, activity, and symptom monitoring recommendations. 
•  Failure to address the multiple and complex medical, behavioral, psychosocial, 
environmental, and financial issues that complicate care, such as older age, 
presence of multiple co-morbidities, lack of social support or social isolation, 
failure of existing social support systems, functional or cognitive impairments, 
poverty, presence of anxiety or depression. 
• Failure of clinicians to use evidence-based practice and follow published 
guidelines in the prescription of pharmacologic and non-pharmacologic therapy. 
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While the Critical Access Hospital provided an education packet to all HF patients, little 
was known about the participation and engagement of patients and families or caregivers.  This 
evidence based educational packet includes comprehensive education strategies and counseling 
for patients and families prior to discharge from an acute care setting (Yu et al., 2006; Boutwell, 
Jencks et al., 2009).  Effective teaching to enhance learning should include “teach back” daily in 
the hospital to assess patients’ and family understanding of discharge care and ability to perform 
them (Weiss, 2007; CAH, 2010 February).  Since teach back was not utilized in this setting, the 
program assistant designed a teach-back plan for the program.  The teaching document entitled: 
“Heart Failure Pilot Program – Patient Teaching “A Stronger Pump” was developed by the 
program assistant to capture key aspects of HF understanding demonstrated by the patients and 
their caregivers (Figure 7).   
According to Weiss (2007) only about 13% of the American adult population have fully 
developed health literacy skills and can read and understand virtually all text and numerical 
information they might encounter in health care settings. Based on the increase in HF 
readmission rates at this CAH, it is important to evaluate if patients understand their role in 
managing HF (Yu et al., 2006).  As part of this HFPP, the HF nurse’s assessed and documented 
the patient and family understanding of their role in management of HF prior to discharging 
them home. 
Consistency with HF Teaching.  In order to maintain consistency in terms of HF 
teaching during hospitalization, key nurses were identified on the medical-surgical unit (2MS) 
and in the critical care unit (CCU) for the day, evening, and night shifts and became known as 
the “HF pilot nurses”.   These nurses were trained by the program facilitator along with the 
program assistant in discussing key aspects of HF care based on the HF Education Packet which 
TRANSITIONS HOME FOR PATIENTS WITH HEART FAILURE  51 
is currently in use at this CAH (Purcell & Fletcher, 2009).  In addition the selected HF pilot 
nurses were instructed to watch a DVD entitled: “Teaching Moments: Educational In-Service” 
by Reske and Rucki (Fairview Hospital [FVH], 2010).  On February 3, 2010 this particular in-
service was presented at the CAH which described various teaching methods in order to enhance 
educational opportunities while caring for patients.  The program facilitator viewed this DVD 
prior to program development to determine if the contents were suitable for pilot 
implementation.  Various components were described in this DVD including but not limited to: 
Ask Me 3 (National Patient Safety Foundation. n.d.).   
A systematic approach was developed and created by the program assistant to aid these 
HF nurses in teaching key factors for HF management (Figure 7).  It is particularly important to 
establish consistency between individuals when teaching patients about HF management or when 
abstracting data from medical or other records (Issel, 2004).   The teaching document allowed all 
HF nurses to follow the educational aspect of this program closely with clear documentation on 
what items were achieved, which in turn allowed the program facilitator to revisit these items 
with HF patients during their scheduled outpatient cardiology appointment. 
All HF patients received education by a designated HF pilot nurse to determine gaps in 
knowledge.  After delivery of patient education, the impact was assessed prior to discharge 
utilizing the “teach-back” and “Ask me 3” methods (Fairview Hosptial, 2010, February; National 
Patient Safety Foundation, n.d.).  The patient and/or caregiver understanding were documented 
by the HF nurse within the patients’ medical record.  Opportunities in documentation were noted 
by the program facilitator and addressed within the evaluation section of this manuscript. 
Post-discharge during the follow-up phone call and outpatient appointment with a 
cardiology trained Nurse Practitioner (NP); patient knowledge was reassessed utilizing the teach-
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back method.  In order to maintain consistency, the same educational HF Packet was referred to 
during follow-up phone calls, and during the outpatient appointment.   
While all HFPP patients received designated HF pilot nurses during their inpatient stay, 
there were several shifts on the medical-surgical unit (2MS) resulting in no HF nurse caring for a 
HF pilot patient.  On several occasions it was due to no HF nurse working the shift pointing to a 
scheduling concern; while on other occasions it was discovered that a HF pilot nurse was 
working the shift, but not assigned to the HFPP patient.  Anecdotal conversations revealed that 
additional education was warranted to the charge nurses on 2MS.  Key managers were informed 
in order to actualize process improvements with HF pilot identification and for proper protocol 
adherence.   
One charge nurse on 2MS recommended that all nurses be “HF nurses” in order to 
minimize additional fall-outs.  Given IRB requirements, any nurse who becomes a designated 
HF nurse for this pilot must complete NIH certification and follow all IRB requirements.     
 Discharge Instructions.  Previous outcome data on HF core measures at the CAH 
demonstrated opportunities for improvement specifically with discharge instructions.  The 
analysis of HF discharge errors identified issues with discharge medications, weight monitoring, 
and smoking cessation counseling (Figure 4).  
The HF core measures reports presentation of the patient discharge instructions, yet there 
were no current measures of the patient understanding of their discharge plan.  Therefore, the HF 
nurse was instructed to assess and document the patient and/or caregiver understanding of HF 
disease management within their discharge note in the computerized electronic medical record 
(EMR).  
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 Discharge “Time-Out”.  Based on the problem identification, a discharge time-out 
document was developed which was completed prior to discharge by the designated HF nurse 
(Figure 5).  This Discharge Time-Out document allowed all HF designated nurses to ensure all 
key items have been addressed prior to discharging HF patients.  The completed form was 
collected post discharge by the program facilitator or program assistant and filed under double 
locks.   
Results of these forms demonstrated that various items were not consistently completed 
by the discharging HF nurse.  During the pilot, efforts were made to convey the importance of 
each item being addressed.  Additionally, it was communicated to the HF nurses that the 
Discharge Time-Out document can be started upon admission in order to ensure all items are 
addressed.   
Follow-up appointment at time of discharge.  Numerous studies and national guidelines 
support the importance of follow-up appointments to a primary care practitioner or specialty 
office at time of discharge; yet no formal process existed at this CAH (Delgado-Passler & 
McCaffrey, 2006; Inglis et al., 2010; Lindenfeld et al., 2010).  A recent study by Jencks, 
Williams, and Coleman (2009) reviewed Medicare claims data from 2003-2004 to describe the 
patterns of re-hospitalizations and characteristics of hospitals.  In the case of 50.2% of the 
patients who were re-hospitalized within 30 days after a medical discharge to the community, 
there was no bill for a visit to a primary care or specialty physician’s office between the time of 
discharge and re-hospitalization (Jencks et al., 2009).  The current evidence on the post discharge 
management of HF recommends that patients recently hospitalized for HF obtain a post-
discharge appointment with their PCP or clinic visit scheduled within 7-10 days post discharge 
(Lindenfeld et al., 2010; Phillips et al., 2005).  This program included nursing follow up on the 
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scheduling of this appointment and patient reminder prior to discharge for every HFPP patient. 
They were documented on the Discharge Time-Out document (Figure 5). 
 Structured telephone follow-up.  National guidelines and research support telephone 
follow-up post discharge to HF patients (Delgado-Passler & McCaffrey, 2006; Inglis et al., 2010; 
Lindenfeld et al., 2010).  In addition, the evidence supports telephone interventions for 
medication counseling and review by an APN with prescriptive authority (Delgado-Passler & 
McCaffrey, 2006). While there has been much discussion and efforts made at the CAH to 
conduct these telephone follow-up calls, it remains unclear how this intervention would be 
systematic or how data would be utilized, tracked, or disseminated.   
For the HF Pilot Program (HFPP), follow-up telephone contact was made by the program 
facilitator (DNP student) or the program assistant within 24-48 hours post discharge utilizing the 
“HF Routine Telephone Call” document (Figure 9).  The completed form was collected after 
telephone contact was established by the program facilitator or program assistant and filed under 
double locks.  This HFPP included availability of the cardiology NP for notification by the 
program facilitator or program assistant if reported patient symptoms required specific advanced 
nursing action.   
Implementation Continued: Monitoring and Modification 
Fidelity   
Fidelity may be defined as the quality or state of being faithful: factual accuracy of 
details and exactness (Merriam-Webster, 2011).  Intervention fidelity refers to the consistency of 
the program implementation, including all elements of the intervention.  There were several tools 
to ensure fidelity which include: DASI Questionnaire, HF Pilot Program (HFPP) Patient 
Teaching “A Stronger Pump”, Discharge Time Out, Post Discharge Follow-Up Phone Call, and 
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HF Pilot Program (HFPP) Patient Satisfaction.  Patients were screened by the program assistant 
beginning January 1, 2011 thru March 31, 2011 focusing on admission diagnosis related to 
dyspnea/shortness of breath (SOB), pneumonia, chest pain, atrial fibrillation, and renal failure. In 
addition, brain natriuretic peptide (BNP) test were also analyzed for potential rule-in/rule-out 
diagnosis of HF.  A screening log was maintained by the program assistant per recommendation 
of the health system IRB.  A total of 64 patients were screened for this pilot, from Jan 1- March 
31, revealing seventeen total candidates.    
Ensuring Educational Fidelity (consistency).  Shortly after initiation of the HFPP, it was 
discovered by the pilot program assistant that a teaching document was needed for all designated 
HF nurses to use in order to gauge education efforts based on the CAH existing HF packet.  
Thus, the data collection document was developed by the program assistant and submitted to the 
IRB for approval with acceptance received on January 3, 2011 (Figure 7).  All HF nurses were 
informed of the need to document their strategies with educational efforts in alignment with the 
education booklet entitled: “A Stronger Pump: A guide for people with all types of Heart 
Failure” (Purcell & Fletcher, 2009).  This document proved to be helpful for all the HF nurses 
with determining how they should focus their educational strategies.  This in turn proved to be 
beneficial for all shifts in gauging where the gaps reside in terms of teaching the patient and their 
caregiver on key aspects surrounding HF disease management.  Items which were not covered or 
required additional attention were addressed during their outpatient cardiology appointment by 
the program facilitator. The program facilitator utilized the same teaching document during their 
outpatient appointment to ensure concepts were understood by the patient and/or caregiver.  
Functional status was measured by the DASI.  This instrument was used for the pre-
program measure (inpatient) and post program measure (outpatient).  The post program DASI 
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was measured at the post discharge NP visit.  For those patients who would be lost to follow-up, 
the program facilitator or the assistant completed the post program DASI by telephone with the 
same instrument. The completed DASI questionnaires for this pilot were entered by the program 
assistant or program facilitator into a BHS owned laptop utilizing an excel spreadsheet; secured 
with double locks.   Completed questionnaires were filed and maintained by the program 
assistant within a secured double lock system. Upon pilot completion, data analysis was 
accomplished on aggregate group results by a biostatistician at the University of Massachusetts 
Amherst for interpretation utilizing appropriate statistical tests.  Individual analysis of results 
was not completed for this HF pilot project to protect anonymity of the data and patients’ 
confidentiality at this time. 
Follow- up visit with Cardiology NP.  The CAH has a full time cardiology NP who 
agreed to see all HF pilot patients post discharge.  An early pilot program change incorporated 
the addition of another NP at the CAH affiliate in order to capture potential HF patients which 
would ultimately allow the CAH to see the affiliate’s patient in the outpatient setting.  Addition 
of this NP to the project staff was submitted via an amendment to the IRB with approval 
received on February 10, 2011.  This new NP was educated by the program facilitator regarding 
various inpatient pilot measures which were currently being captured at the CAH such as 
administration of the DASI, patient education with the CAH booklet with documentation form, 
and discharge time out.  The NP agreed to notify the program facilitator with potential patients 
which would then be followed by the CAH on an outpatient basis.  Despite the addition of this 
NP from the CAH affiliate, no new patients were captured for this particular pilot program.  
Should this HFPP lead to adoption, collaborative agreements between both facilities deserve 
attention. 
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Research Training.  The IRB notified the program facilitator in mid February, 2011, 
regarding project staff for this pilot.  It was noted that several of the designated HF nurses did 
not achieve National Institute of Health (NIH) Certification regarding protection of human 
subjects which is a requirement by the Critical Access Hospital IRB when incorporating these 
HF nurses as project staff.  It was determined that the remaining nurses who did not have their 
NIH certification (13 nurses), must complete that process in order for the HF project to continue 
along with submission of their signatures on the project staff IRB form.  Thus, the program 
facilitator worked with these 13 nurses and coached them on how to obtain NIH certification.  
Within a three to four week period, all designated HF nurses were NIH certified along with 
submission of their project staff forms to the Critical Access Hospital IRB.  There were a total of 
22 designated HF nurses for this pilot project.  A sixth amendment form was filed with the IRB 
regarding the project staff update listing all 22 HF nurses; amendment approval was received on 
March 15, 2011. 
Adaptability 
This may be described as the ability to change or be changed in order to fit or work better 
in some situation or for some purpose: or be adapted to change to fit changed circumstances 
(Merriam-Webster, 2011).  According to Melnyk and Fineout-Overholt (2005) it is essential to 
have a written strategic plan with clearly described goals for a change in evidence-based practice 
(EBP) to occur.  Additionally, lack of a detailed plan is a major barrier to implementing a 
change.   
It was anticipated and observed with this HFPP that the identified HF nurses would vary 
in their individual personality styles while implementing the HFPP which ranged from “drivers”, 
“inspired”, “supportive and steady”, to “contemplators” (Melnyk & Fineout-Overholt, 2005).  
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The program facilitator was responsible for this change effort by facilitating strategies to work 
successfully with each of them.  It was soon discovered that varying degrees of skepticism would 
occur if the change is not clearly understood, if they are fearful about it, or if they have 
misperceptions about why change is needed.   
In order to ensure adaptability, the program facilitator and program assistant frequently 
visited the inpatient units throughout this HFPP.  Educating the HF nurses about this EBP change 
was an ongoing endeavor from the beginning of this HFPP to the end.  Prior to the start of this 
HFPP, the program facilitator met with all HF nurses on the medical surgical floor and during a 
staff meeting on the critical care unit (CCU) to discuss how this pilot would be rolled-out.  A 
“Heart Failure Pilot Program”(HFPP) note book was made by the program facilitator and 
program assistant for use on each unit with detailed instructions regarding all necessarily 
documents on how to capture the necessary HFPP data as well as the program facilitator and 
program assistant contact information.  All HF nurses were encouraged to contact them during 
the pilot for any assistance or clarification.  Electronic messages from the program facilitator 
were also used in order to maintain communication efforts during this pilot.  All HF nurses were 
asked to provide any feedback, comments, or suggestions regarding pilot measures or potential 
for improvements. 
Anecdotal verbal responses from the HF nurses were obtained by the program facilitator 
while visiting the inpatient units at the CAH.  Comments derived from the medical-surgical unit 
(2MS) pointed to the overabundance of paper work during the discharge process which may be 
displaced and not necessarily due to this particular pilot.  Other anecdotal verbal responses by 
some of the HF nurses pointed to positive aspects of this pilot including how much they learned 
along with their patients and caregivers with the enhanced teaching portion.   
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Previously discussed in this paper, the Awareness-to-Adherence Model applied the Heart 
Failure Society of America (HFSA) guideline as a key reference source for this HFPP 
(Lindenfeld et al., 2010).  This model was chosen in order to increase practitioner use of the 
guideline recommendations with HF patients during the acute care hospitalization, and discharge 
process.  For ease of access, the Heart Failure Society of America (HFSA) guideline was printed, 
placed in a binder, and made available on the 2MS unit for all project staff and clinicians as a 
reference guide surrounding heart failure care.  
The entire hospitalist group and cardiology group demonstrated positive support for this 
HFPP.  They informed the program facilitator when potential candidates were identified and 
shared results of diagnostic studies.   
Results, Data Analysis, and Interpretation 
As more funding agencies require health programs to document their success, the 
evaluation becomes more integral to the actual intervention and overall program delivery (Issel, 
2004).  The program facilitator monitored and recorded the baseline outcomes.  These were 
major components of the process evaluation.   
Patient screening and tracking endeavors were conducted by the program assistant and 
program facilitator which were entered into an excel spreadsheet as recommended by the Critical 
Access Hospital IRB.  The CAH Quality Management Department assisted the project with 
developing an excel spreadsheet to track and monitor patient education outcomes and DASI 
results. 
Population Results 
Out of 67 patients who were screened, there were a total of 17 participants who received the 
inpatient HFPP (Table X).  
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Table X.  Number of HF pilot participants n = 17 
Number of patients receiving inpatient pilot program to its entirety 17 
Number of patients receiving outpatient pilot program to its entirety  11 
Number of patients who were lost to follow-up 6 
Number of patients who completed the inpatient & outpatient DASI  13 
Number of patients receiving portions of the inpatient pilot program, 
but were excluded prior to discharge 
8 
Number of HF pilot patients readmitted within 30 days (due to HF) 1 
Number of patients seen for an emergency room visit post discharge 
from HF Pilot program (treated and released) 
2 
Number of patients who expired requiring reporting to CAH IRB              
(one inpatient; two outpatient) 
3 
Number of returned patient satisfaction survey’s    12 
 
There were a total of 17 patients who received the inpatient portion of the HFPP during their 
hospital stay.  Six of those patients were lost to follow-up; three of the six expired (one inpatient 
and two outpatient deaths); one patient resided in another state and had two readmissions during 
the pilot program (patient number 105 and 112) with the first admission and subsequent two 
readmissions lost to outpatient cardiology follow-up.  Further analyses of these patients will 
occur within the readmission and mortality discussion.   
Eleven patients (65%) completed the entire HFPP (inpatient & outpatient) with continued 
care in the outpatient cardiology department.  During their outpatient appointment with the 
cardiology NP and program facilitator, a physical assessment was obtained including weight, 
blood pressure, and observing for any physical assessment signs of heart failure.  In addition, 
medications were reviewed and discussed along with adjustments being made by the NP if 
warranted.  Heart failure education was reviewed by the program facilitator utilizing the same 
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approach as noted during their inpatient hospitalization at the CAH.  Of the eleven patients seen 
in the outpatient HFPP, one patient was sent to the emergency room for evaluation of tachycardia 
with a HR of 140, and one patient required an outpatient chest x-ray due to notable dyspnea with 
lung auscultation revealing course crackles; this patient refused emergency room evaluation.  
This patient was ultimately readmitted several days later with worsening symptoms.  Further 
analyses of this particular patient will occur within the readmission discussion. Both of these 
cases represent proactive symptom management that could have avoided emergency situations.   
A total of eight patients received portions of the inpatient HFPP during the ruling-in / ruling-
out process primarily due to a questionable diagnosis of HF.  As described in the heart failure 
guideline, HF is a syndrome with notable co-morbidities such as pneumonia, renal failure, and 
pulmonary congestion.   It became apparent during the inpatient aspects that HF may not be 
readily identified due to underlying co-existing conditions.  Chest X-Ray was not always 
definitive nor having an elevated BNP level.  Thus, during the ruling-in/ruling-out process 
several patients who were thought to have HF did not, and vice versa. 
Follow-up Phone Calls.  Fifteen patients received a telephone follow-up call 24-72 hours 
post discharge.  During this pilot, the cardiology NP was notified once regarding a patients 
discharge medication.   It was determined by this NP that no additional intervention was 
warranted since the patient had enough medication and was scheduled to be seen in the 
outpatient setting whereby all medications would be reviewed. 
Patient Satisfaction.    Patient Satisfaction was measured with a tool developed for this 
program.  The same survey was used for all patients in the program.  A total of 12 satisfaction 
surveys were obtained.  Mean scores were calculated for each question utilizing an excel 
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spreadsheet (Tables XI-XIII).  Each item was based on a likert scale ranging from very poor = 1, 
to very good = 5, which can be reviewed in figure 7 of this manuscript.   
Table XI. 
A.  In-patient Education (Your hospital stay) 
 
Average 
Score 
1. The education portion was effective in 
     teaching me new information and  
     reinforced information I already knew. 
 
4.9 
 
2. The nurses presented the education  
material with enthusiasm. 
 
5 
3. The nurses were knowledgeable and  
well prepared to present education material. 
 
4.9 
4. The education sessions covered all   
     necessary information and answered  
     my questions. 
 
5 
 
Comments: 
Pt. #1:  Per patients’ spouse: "Care at this hospital was excellent, however, they 
didn't send his records down to FL and it was urgent at the time." 
Pt. #6:  "Beds lumpy & uncomfortable. Night & day nurses are great. Night 
assistants too noisy". 
Pt. #12 - "The nurses were very empathetic to my condition & very helpful in 
teaching thoroughly my new conditions and needs" 
 
Table XII. 
B.  Out-patient Education (In the Cardiology Dept.) 
 
Average 
Score 
5. The education portion was effective in 
     teaching me new information and  
     reinforced information I already knew. 
 
4.7 
 
6. The nurse practitioner(s) presented the 
education material with enthusiasm. 
 
4.8 
7. The nurse practitioner(s) were knowledgeable 
and well prepared to present education 
material. 
 
4.9 
 
8. The education sessions covered all   
      necessary information and answered my 
      questions. 
 
4.8 
 
Comments: 
Pt. #7:  "I was very pleased" 
Pt. #11:  "Unfortunately you do not offer preventative care program which makes 
some of this info null & void" 
Pt. #12 - "I'm very satisfied with the services provided to me" 
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Table XIII. 
C.  Facility and Nursing   (Overall)                             Average 
Score 
9. All staff provided an appropriate level 
customer service. 
 
4.9 
10. The heart failure program 
      provided all the information I needed. 
 
4.8 
11. The facilities are clean and safe. 4.9 
12. Please rate the overall care you received 
during the program.  
 
4.9 
Comments: 
Pt. #4:  "Very happy with all" 
Pt. #12: "The doctors, nurses, and all help acted and provided my needs above the 
appropriate standard of service" 
 
Six surveys revealed brief comments.  Handwritten comments have been shared with the HF 
nurses and department managers.  Anecdotal verbal responses obtained from patients during 
their outpatient appointment included: “How much they learned about HF” and “I’ve never been 
taught this much before”.   
Readmission  
The breakdown on reasons for readmission demonstrated five 30-day all-cause 
readmissions (30%) during the pilot program period from Jan 1 – March 31, 2011 (Table VII).  
However, according to Table VII, only one patient was readmitted specifically due to previous 
HF care (5.88%).  One particular patient deserves close attention given that this patient received 
the inpatient program initially in January, but was readmitted in February (patient number 105), 
and again in March (patient number 112).  In addition, this patient was lost to cardiology 
outpatient follow-up since the established cardiologist who was involved with the care of this 
patient, resided out of state.  Thus, this patient did not participate in the outpatient HF aspect of 
this program.  The HFPP facilitator identified a local primary care practitioner (PCP) for this 
patient, after the patient was discharged in March.  
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Attempts could have been made during previous admissions for this patient in 
establishing a follow-up appointment with the local PCP in order to avoid any additional 
readmissions.  While this patient was told to follow-up with his PCP per documentation in the 
medical record, no follow-up appointment was made on behalf of the HF nurse or the case 
management team.  Lost opportunities were realized after the second readmission by the program 
facilitator in terms of ensuring this patient had a follow-up appointment with the designated PCP. 
Care across State Lines.  One patient was unable to complete the entire program because 
they lived in a different state from the CAH.  Efforts were made by the program facilitator to 
determine how to best manage care with patients who reside out-of-state with both the hospitalist 
group and the case management department.  The quality management department in 
conjunction with the case management department has developed a focus study regarding 30-day 
readmissions.  Key questions are being obtained from readmitted patients to aid the CAH in 
recognizing opportunities for improvement.  While the PCP listed for this particular patient 
resides locally, there were no documented efforts made to contact this PCP in order to discuss or 
establish timely follow-up care in order to avoid unnecessary readmissions.    
 Readmission for patient number 108 suggests it was due to inpatient heart failure 
management with carvedilol (Coreg) 25mg bid being prescribed one day prior to discharge.  The 
patient had an adverse reaction once discharged home due a syncopal event with loss of 
consciousness prompting emergency service notification.  The patient was subsequently 
readmitted with the carvedilol dose being decreased to 12.5 mg daily which was tolerated well.   
Patient number 115 deserves attention as well given that the first initial presentation in 
March resulted in a lengthy hospital admission of 11 days and 9 days for the subsequent 
readmission period.  Although the NYHA classification system is not utilized at the CAH, this 
TRANSITIONS HOME FOR PATIENTS WITH HEART FAILURE  65 
patient would have likely been staged as class IV due to a reported ejection fraction of 20% with 
symptoms of cardiac insufficiency present at rest (Lindenfeld et al., 2010).  In addition to being a 
bilateral amputee, multiple co-morbidities have been established with this patient pointing to the 
rationale for the lengthy admissions.  A follow-up phone call was attempted with this patient 
after the initial admission yet the patient was not available nor was the phone call returned to the 
program facilitator or assistant by this patient.  Fortunately, the patient appeared for the 
cardiology outpatient appointment with the NP and program facilitator less than 10 days post 
discharge after the initial admission revealing significant sedation due to narcotic use, SOB, 
diaphoresis, right basilar crackles with scattered wheezes and diminished left base.  This patient 
refused emergency room evaluation, but agreed to an outpatient chest x-ray and labs; results 
were reviewed by the NP and cardiologist.  Two days later, the patient appeared in the 
emergency room with worsening SOB and admitted with a questionable diagnosis of HF versus 
pneumonia.  After another lengthy admission of 9 days, the patient was notified via follow-up 
phone call by the program facilitator reportedly doing the same, denying any worsening 
symptoms.  The outpatient appointment in the cardiology department was made prior to 
discharge, but this patient reportedly rescheduled for factors unknown.  Histories of non-
adherence to therapeutic interventions were noted with this particular patient.   
Of particular interest with this patient (#115) points to the verbalization of dissatisfaction 
in not being accepted for the cardiac-rehab program at this CAH.  Criteria for acceptance into 
cardiac-rehab do not include a diagnosis of HF.  According to Stevens (2009) the Centers for 
Medicare and Medicaid Services (CMS) recognizes myocardial infarction (MI), coronary artery 
bypass grafting (CABG) surgery, stable angina pectoris, percutaneous coronary intervention 
(PCI), heart valve repair or replacement, and heart transplantation as additional indications for 
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formal cardiac rehabilitation.  CMS declined to add HF as an indication. However, CMS 
signaled that it is waiting for the results of a current U.S.-wide trial on HF and would reconsider 
this indication in light of its results (McDermott Will & Emery, 2011).  Despite these 
explanations, patient #115 asked:  “Do I need to get worse before I get better to qualify?”  
Clearly, a question which prompts much thought on behalf of all clinicians especially in light of 
the importance surrounding physical exercise.   
Mortality 
Three patients (17%) expired during the three month HFPP period.  One patient expired 
during inpatient hospitalization, and two expired post-discharge.  Hospital mortality rates include 
those patients who expire during their hospitalization; outpatient mortality is not accounted for.  
Despite this, two patients who expired and listed in a local newspaper was noted by the program 
facilitator and reported to the IRB.  Thus, a mortality rate for inpatient deaths during this pilot 
resulted in one patient (5.8%).  It was determined that the inpatient death was not due to HF, 
rather it was presumed to be a pulmonary embolism as the identified cause. 
Functional Status: Interpretation of DASI scores 
The DASI pre program and post program scores were entered into SPSS and the 
distribution of scores demonstrated a normal distribution for both the inpatient and outpatient 
oxygen (O2) uptake scores (Figures XI-XII).  Thus, it can be assumed that the populations from 
which the samples are taken are normally distributed (Pallant, 2007). 
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Figure 12.  Inpatient O2 Oxygen Uptake Distribution 
 
Figure 13.  Outpatient O2 Oxygen Uptake Distribution 
Paired T-Test was conducted to compare inpatient vs. outpatient of O2 uptake. Average 
difference between inpatient and outpatient values (inpatient O2 uptake is higher) equaled 1.73. 
There was no significant difference in scores for inpatient (M = 20.99, SD = 6.42) and outpatient 
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(M = 19.26, SD 5.28), t value = .94, df = 12,  p = .36 (two-tailed). Wilcoxson Signed Rank Test, 
non-parametric test of differences, demonstrated no statistical difference between inpatient and 
outpatient oxygen (O2) uptake; z = -.839a, p =  .40, the median score on the inpatient O2 
uptake(Md = 5.58) to post discharge outpatient O2 uptake (Md = 8.21).    Despite no statistical 
difference between inpatient and outpatient oxygen (O2) uptake scores, the DASI can serve as a 
useful role in the follow-up evaluation of patients.  Individual results from inpatient to outpatient 
DASI scores should be reviewed during the outpatient appointment in order to gauge level of 
functional capacity which may aid in establishing various treatment plans along with targeted 
risk management to improve prognosis. 
Gender.  An independent-samples t-test was conducted to compare O2 uptake changes 
based on gender.  On average, inverse relationship from outpatient vs. inpatient O2 uptake 
decreased by 2.3 for females (F = 2.32, SD = 6.69) and males 0.8 (M = .79, SD = 7.24); t value = 
.38,  df = 11, p = .705  However, this difference between males and females’ change in O2 
uptake is not statistically significant.  Additionally, t-test of age by gender demonstrated average 
age of 5 males in study is 75, 9 females’ average age is 69.  Difference between males’ and 
females’ ages is not statistically significant (p = .403; two-tailed).   
Age.  Pearson correlation or Spearman correlation was used to give the direction and 
strength of the relationship between variables (Pallant, 2007).  A moderate correlation was 
detected with age and O2 uptake change from outpatient vs inpatient, (p < 0.05).  Additionally, 
the distribution of data points suggests a correlation is present when drawing a straight line 
through the main cluster of points (Figure XIII). (Pallant, 2007).   
TRANSITIONS HOME FOR PATIENTS WITH HEART FAILURE  69 
 
Figure 14.  Age vs. Change in O2 Uptake by Gender 
An independent-samples t-test was conducted to compare O2 uptake changes based on age.  
Average O2 uptake decreased by 7 for patients 70 or under (M = 7.00, SD = 4.82), and increases 
by 3 for those over 70 (M = 2.77, SD = 4.19); t = 3.91, df = 11,  p = < 0.01.  Explanations for 
this inverse detection are intriguing suggesting that functional capacity may improve with 
increasing age post discharge.  These results suggest that older people are potentially benefitting 
from the inpatient interventions.  The usefulness for clinical decision making regarding lower O2 
uptake scores for those under 70 compared those over 70 cannot be explained or understood 
given the surprising nature of this result.  The fact that other clinical factors are also independent 
predictors of functional capacity indicates that an uncomplicated course of inpatient heart failure 
designated care is not, in of itself, sufficient to guarantee an optimal functional outcome (Jaeger 
et al., 1994).  It is, however, an interesting factor to consider in conducting research on HF. 
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Five variables and O2 uptake change.  Five additional variables were analyzed to determine 
if any relationship occurred with O2 uptake change as noted in changes in DASI.  There were a 
total of 13 patients who completed the inpatient DASI and the 7-10 days post discharge DASI.   
The five variables included key items for the pilot program.  Independent-samples t-test was 
conducted for all five variables as listed to compare O2 uptake changes based on each variable. 
a. HF Education: 0 = not fully completed; 1 = fully completed 
Three patients were not fully completed (M = .43, SD = 2.64); 10 patients were fully 
completed (M = -2.38, SD 7.44); (t (11) = .626, p = .544 [two tailed]). This was not 
statistically significant.  
b. Teach Back Method:  0 = was not able; 1 = was able 
Two patients were unable (M = 7.5, SD = 5.16); 11 patients were able (M = -3.41, SD = 
5.49); (t (11) = 2.60, p = .024 [two tailed]).  This is statistically higher at p < 0.05.   
Especially surprising about this result is that average O2 uptake change of 7.5 for 2 
patients who were “unable to teach back” is significantly higher, than average O2 uptake 
change of -3.4 for 11 patients who were “able to teach back”.  The scores of the 2 patients 
that “were unable” went up, while those that “were able”, went down on average.  
c. Inpatient Nutrition Consult: 0 = no; 1 = yes 
Two patients did not have a nutrition consult completed (M = -.107, SD = 3.49); 11 
patients had a consult (M = -2.03, SD = 7.16); (t (11) = .362, p = .724 [two tailed]).  This 
was not statistically significant.  
d. DC Time Out:  0 = not fully completed; 1 = fully completed 
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Two patients were incomplete (M =1.34, SD =.22); 11 patients were fully completed (M 
= -2.29, SD =7.13); (t (11) = .696, p = .501 [two tailed]). This was not statistically 
significant.  
e. Follow-up with NP:  0 = no; 1 = yes 
Two patients did not see NP (M = 2.15, SD = .304); 11 patients saw NP (M = -2.44, SD = 
7.03); (t (11) = .890, p = .393 [two tailed]).  This was not statistically significant.  
Project Limitations 
This project had several limitations.  A review of the literature conducted by the author of 
this paper found that HF programs often resulted in decreased hospitalizations (Willey, in press).  
While most disease management programs for HF seem to work by reducing hospital length of 
stay or readmission rates, the impact is not always statistically significant, as noted within this 
three month HFPP, and the success of these programs may be a function of the types of patients 
enrolled based on the severity of their illnesses (vanVonno, Ozminkowski, Smith, Thomas, 
Kelley et al., 2005).  In our HFPP, we did not stratify program participants by risk status and 
control for differences in co-morbidities; thus, severity of illness varied widely among all pilot 
participants.  Despite the intricacies involved in adjusting for differences, a comparison group 
may be used which remains an option for this CAH to develop and implement with IRB 
guidance.  Otherwise, it may not be possible to infer whether observed changes are really due to 
program participation (vanVonno et al., 2005). 
Second, the responses to the questions on the DASI are subjective and may be affected by 
patient factors and by method of administration. Given the number of HF nurses, method of 
administration will vary.  However, in the outpatient setting, the DASI was administrated by the 
same individuals: the program facilitator or the program assistant.  In addition, the DASI has 
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been validated in younger patients, but has not been separately validated in older patients (Jaeger 
et al., 1994).  One study by Arena, Humphrey, and Peberdy (2002) attempted to assess the 
reliability or validity of the DASI in HF population with a small sample size of 33 participants.  
Future research is needed to determine if this questionnaire holds value in the HF population 
group (Arena, Humphrey, & Peberdy, 2002). 
Third, there were scheduling challenges to ensure that a HF nurse care for a HFPP 
patients during the inpatient stay.  While all HFPP patients had a HF nurse caring from them 
while inpatient, there were several shifts when HFPP patients did not have a designated HF nurse 
either due to one not working or inability to change assignments to allow a HF designated nurse 
to care for a HFPP patient.  Clearer scheduling protocols need to occur to allow HF nurses to 
care for HFPP patients.  While these strategies may require change in assignments, discussions 
regarding protocol adherence with the department managers, charge nurses, and HFPP 
champions must continue in order to evaluate missed opportunities.   
 Fourth, given the scope of this HFPP, inclusion criteria applied to patients who were 
being discharged home since outpatient cardiology follow-up seemed most likely to occur.  
Patients who were transferred to another acute care hospital or extended care facility were 
excluded based on potential for loss to follow-up in the outpatient cardiology setting; however, 
waivers were granted for the two patients who were transferred to another acute care facility 
since they were inadvertently included in the pilot.  Both of these patients returned for outpatient 
cardiology follow-up and thus deemed to be good candidates for the outpatient pilot program. It 
was determined that patients who are transferred to another acute care facility require careful 
consideration in terms of follow-up care.   Nevertheless, this finding supports the contention that 
transferred patients may benefit by being included in the CAH HF pilot program. 
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Fifth, seven patients received portions of the inpatient HFPP, but were excluded due to 
discharge disposition to a skilled nursing facility (SNF), consideration of this population group is 
warranted.  Gaps remained in those discharged to SNFs which deserve further attention 
regarding inclusion in the HFPP providing follow-up in the outpatient cardiology setting can be 
achieved.  Furthermore, opportunities exists for nurse case management to develop a follow-up 
phone call process within 48 hours of discharge to the registered nurse/licensed practical nurse in 
the SNFs to verify or clarify discharge instructions which may improve continuity of care 
(Jacobs, 2011).  Tracking of the SNF population group requires further tightening should the 
program continue.  Additionally, it may be beneficial for various SNF patients to receive the 
inpatient HFPP despite the likelihood of loss to follow-up.  If program adoption occurs, 
incorporating this population group warrants additional discussion among all key stakeholders. 
Conclusion 
The purpose of an evaluation is to learn about the facilitators and barriers to program 
implementation.  Thus, negative or unexpected results should be viewed as opportunities for 
discussions about how to better organize programs, how to run them more effectively, and how 
to best work with patients and their providers (vanVonno et al., 2005).  An appealing benefit of 
conducting an evaluation pilot program is that these discussions can occur prior to full-scale 
rollout.  Additionally, a pilot study is critical in determining the feasibility of subject enrollment, 
the intervention, the protocol or data collection plan for the study, and the likelihood that 
subjects will complete follow-up measures (Melnyk & Fineout-Overholt, 2005, p. 266).  
What we learned about this pilot program is that it takes a considerable time to 
implement and monitor all aspects in order to ensure the protocol is being followed appropriately 
by all HF nurses.  Discussions with the CAH senior managers will need to be maintained during 
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this pilot in order to keep the momentum going with all pilot features including, but not limited 
to, communication with unit managers in order to maintain their commitment and full 
engagement to this project. 
Dissemination of Findings 
Results have been shared with key stakeholders at the CAH including all aspects of the 
pilot features.  Formal presentations occurred at the CAH on April 28, 2011 and on campus at 
the University of Massachusetts, Amherst on May 12, 2011.  If suitable for publication, the IRB 
will be notified to determine status of this pilot.   
Program Continuation 
Several of these HF interventions have been proven in the literature to lower readmission 
rates after HF hospitalization, including improved hospital and post-discharge care, pre-
discharge planning, home-based follow-up, and patient education (Ross et al., 2010).  Findings 
from this CAH pilot support program continuation.  Additional data with a larger sample size 
may result in actualization into a formal HF program.  Plans for post-project continuation and 
implications for future practice and translational research initiatives have been determined by 
senior management at the CAH.  On April 1, 2011 the CAH Chief Nursing Officer determined 
program continuation for an additional three months projecting to end on June 30, 2011.   
Heart Failure nurse champions on the 2MS unit and CCU have been selected to assist in 
overseeing project protocols along with the aid of the program assistant.  The project facilitator 
will be available for consultation as needed.  The goal of these champions will be to ensure 
potential patients are identified and included in the HFPP, and that the three pilot forms are 
instituted and fully completed.  Results of specific outcome indicators noted in Tables II-V of 
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less than 100% have been shared with all project staff and their managers in order to identify 
opportunities for improvement. 
Additional concerns point to the following: 
Considerations to data tracking and entry will be carried-out by the program assistant 
with oversight by the program facilitator; follow-up phone calls will be carried-out amongst the 
designated HF nurses on 2MS and CCU with oversight by the program facilitator and assistant in 
ensuring calls are made within the protocol timeframe. 
On two occasions during this HFPP, patients who were transferred to another acute care 
facility were inadvertently placed on this pilot despite meeting the exclusion criteria.  However, 
both patients were deemed appropriate for this HFPP since both patients would eventually be 
seen by the NP in the outpatient cardiology department.  Therefore, the program facilitator 
modified the inclusion criteria for two patients.  This particular exclusion as listed in the protocol 
may warrant modification with an IRB amendment in order to capture patients who would be 
seen for follow-up in the outpatient cardiology office. 
In the outpatient setting, the NP has agreed to administer the outpatient DASI and 
provide satisfaction questionnaires to program participants.  The NP will provide these 
documents to the program assistant for data entry.  Since the protocol requires a second DASI 7-
10 days post discharge, it will be important for the program assistant to be aware of any patient 
who is not scheduled to be seen in the outpatient setting.  Communication patterns regarding 
protocol adherence requires additional attention for all project staff to ensure discrepancies are 
minimized and opportunities for improvements are addressed. 
 As previously stated, comments derived from 2MS pointed to the overabundance of 
paper work during the discharge process which may be displaced and not necessarily due to this 
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particular pilot.  Should this HF program be adopted this explicit concern should be addressed 
with all HF designated nurses and the CAH in order to streamline inpatient HF documentation.  
A key aspect of what we learned during this pilot program points to constant vigilance and 
frequent reminders with all HF nurses in ensuring HF pilot protocols utilizing evidence-based 
care is carried out during the entire admission period.  Communication patterns with the project 
staff must continue in order to ensure potential HF patients are not missed or that protocol 
adherence is not followed properly.  Furthermore, extra assistance and guidance in developing 
expertise for all nurses in HF care may be warranted should this pilot prove to be effective in 
hospital-based outcome measures.     
Lastly, should program adoption occur, components for information systems should also 
be reviewed for electronic medical record (EMR) purposes specifically in terms of meaningful 
use.   
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Figure 1.  Critical Access Hospital HF Process Measures Year 2010 
Critical Access Hospital (2011, March).   
 
94%
86%
100%
85%
92%
50%
60%
70%
80%
90%
100%
2007 2008 2009 2010
CAH Appropriate Care Score National Top 10% (4th Q 09)
National Average (4th Q 09)
 
  
2007 2008 2009 2010 
Num 29 31 38 40 
Den 31 36 38 47 
 
Figure 2.  Critical Access Hospital HF Appropriate Care Score 
Critical Access Hospital  (2011, March).   
4Q’s - 2010 
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Figure 3.  Critical Access Hospital (CAH) HF 30 Day All-Cause Readmission Rate 
Critical Access Hospital (2011, March).   
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Figure 4.  Appropriate Care Score (ACS) Breakdown 
Critical Access Hospital (2011, March).   
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DISCHARGE TIME OUT - Heart Failure (HF) Pilot Program 
Heart Failure (HF) Specific Considerations / Management Issues 
  
o LVF assessment: Has the patient ever had an ECHO? Y/N   
o ACE or ARB for EF less than 40% - Contraindication 
documented? Y / N 
o Beta Blocker for EF less than 40% - Contraindication 
documented? Y / N 
o Submit diet consult through 
Meditech 
o Call Nutrition Center: xxx-
xxxx for outpt nutrition 
appointment 
NURSING 
o Enhanced admission assessment includes: identification of caregivers for D/C planning & 
predicting post hospital needs.  
o Duke Activity Status Index (DASI) given to patient and completed shortly after admission 
o Determine need for smoking cessation / counseling  
o Did the pt. smoke anytime during the 12 mths prior to hospital arrival?  Y / N    If yes, document 
if pt. declined or received smoking cessation counseling. 
o Patient/caregiver education completed and documented nurses note utilizing “teach back” & 
“Ask me 3” techniques  
o Document pt. understanding (or caregiver) of HF disease management in discharge nurses note in 
Meditech 
o Discharge Instructions must address:  physical activity, diet, follow-up, medications, worsening 
symptoms, and weight monitoring 
o FVH heart failure education packet given to patient / caregiver 
o Medication reconciled 
o Medication profile reviewed with patient and/or caregiver 
o Prescription given to patient/caregiver 
o Nursing Home/Home Care referral completed, patient/caregiver given copy for Home Care 
o Pnuemovax/flu vaccine given if applicable 
o HF out-patient appointment scheduled with Cardiology FNP  ___________________                     
                                                                                 Call Cardiology: ext 9777 
o Patient instructed regarding out-patient cardiology appointment 
o Patient instructed regarding follow-up blood work, if needed. 
o Scale provided to patient and/or caregiver if needed         
                              NOTE: Staple Med Rec and DC Instructions to this form after discharge 
 
“HF” Nurse Name: ________________________Date of Patient Discharge:_______________  
Figure 5.  DISCHARGE TIME OUT - Heart Failure (HF) Pilot Program 
 
 
Trial form for HF Pilot Program 
2011 
 
TRANSITIONS HOME FOR PATIENTS WITH HEART FAILURE  93 
 
 
Figure 6.  Duke Activity Status Index (DASI) A Self-Administered Questionnaire 
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HEART FAILURE PILOT PROGRAM  -  Patient Teaching  
 “A Stronger Pump” 
Category Pages Nurse 
providing 
education 
Patient able 
to teach 
back? 
Yes or No 
Patient unable to teach back 
(please comment) 
Heart failure 2    
How you may feel 3-6    
Heart failure testing 7-9    
Medical treatment 10-17    
Surgery for heart 
failure 
18-20    
Your role in heart 
failure control 
21-30    
In summary 31    
Causes of heart 
failure 
32-37    
Congenital heart 
disease 
38-39    
Managing heart 
failure at home 
40    
 
“Stop Light Education” 
Category Nurse 
providing 
education 
Patient able 
to teach 
back?  
Yes or No 
Patient unable to teach back 
(please comment) 
Green Zone    
Yellow Zone    
Red Zone    
 
Nurse  Initials Nurse  Initials 
    
    
    
 
Figure 7.  HEART FAILURE PILOT PROGRAM - Patient Teaching - “A Stronger Pump” 
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HEART FAILURE PILOT PROGRAM - Patient Satisfaction  
Your comments and concerns are very important to us.  We are 
continually trying to improve our heart failure pilot program.  Please 
take a moment to complete this survey and return it in the provided self 
addressed, stamped envelope. 
 
Directions:  Please circle the number that corresponds to your rating for 
each program part – with 5 being the highest rating and 1 being the 
lowest rating.  Please provide detailed comments for each area. 
 
A.  In-patient Education (Your hospital stay) 
                                                                                      Very                                                  Very 
                                                                                                                                                       good         good       fair      poor      poor 
13. The education portion was effective in 
     teaching me new information and  
     reinforced information I already  
     knew. 
5 4 3 2 1 n/a 
14. The nurses presented the education  
material with enthusiasm. 
 
5 4 3 2 1 n/a 
15. The nurses were knowledgeable and  
well prepared to present education 
material. 
5 4 3 2 1 n/a 
16. The education sessions covered all   
     necessary information and answered  
     my questions. 
5 4 3 2 1 n/a 
Comments: 
 
 
 
 
      
 
B.  Out-patient Education (In the Cardiology Dept.) 
                                                                                      Very                                                 Very 
                                                                                                                                                       good      good       fair        poor      poor 
17. The education portion was effective in 
     teaching me new information and  
     reinforced information I already  
5 4 3 2 1 n/a 
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     knew. 
 
 
18. The nurse practitioner(s) presented the 
education material with enthusiasm. 
 
5 4 3 2 1 n/a 
19. The nurse practitioner(s) were 
knowledgeable and well prepared to 
present education material. 
5 4 3 2 1 n/a 
20. The education sessions covered all   
     necessary information and answered  
     my questions. 
5 4 3 2 1 n/a 
Comments: 
 
 
      
 
C.  Facility and Nursing   (Overall)                             Very                                                   Very 
                                                                                                                                                      good         good     fair        poor       poor 
1. All staff provided an appropriate level 
customer service. 
5 4 3 2 1 n/a 
2. The heart failure program 
     provided all the information I needed.  
5 4 3 2 1 n/a 
          3.  The facilities are clean and safe. 5 4 3 2 1 n/a 
3. Please rate the overall care you received 
during the program. 
5 4 3 2 1 n/a 
Comments: 
 
 
      
Thank you very much for taking the time to complete this survey. 
 
Figure 8.  HEART FAILURE PILOT PROGRAM - Patient Satisfaction  
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Patient’s Name: ___________________________________Date of call: _________________ 
ID No.: ___________________________________________Date of D/C: ________________ 
Cardiologist: _____________________________________ Primary MD: ________________ 
 
 
1.  Current symptoms 
 Chest pain/discomfort                                                                   
 Shortness of breath                               
 Palpitations 
 Night time SOB 
 Dizziness 
 Fatigue                                               
 Edema of legs, ankle, & / or abdomen  
o Is this a change_______________________________________________________________________ 
 If any of the above are checked, please page Cardiology NP @ #9739 
 Weight today: _________________lb         
o Change ___________________lb   
o Hospital discharge weight:_______________lb     
o Initial Home weight:____________________lb 
 If patient gains >2lbs/24 hours or 5 lbs in 1 week, please page Cardiology NP  @ #9739 
o 2000 mg sodium (salt) restriction compliance? ____________________________________________ 
o Other (specify) _______________________________________________________________________ 
2.  Change in symptoms:   Overall, how are your symptoms compared to 2 days ago? 
  Better          About the Same        Worse (describe)   ________________________________________ 
o If patient describes symptoms as “worse” please page Cardiology NP @ #9739 
3.  Current treatments 
 Medication changes (for CHF) 
o Were you able to get all your medications from the pharmacy? 
o Any issues with current medications? 
o Any questions understanding your medication list? 
o Discharge medication profile attached 
4. “Can you tell me the name of your water pill?”____________________________________________________ 
5.  “Are you using the stop light visual”? ___________________________________________________________ 
  “Can you tell me what amount of weight gain you should report to your doctor?”________________ 
  “Which doctor would you report those symptoms to?”________________________________________ 
6. “Have you had an Echocardiogram of your heart recently”?_________________________________________ 
7. “Have you recently had counseling about stopping smoking”?______________________________________ 
 
 
 
 Contacted Cardiology, FNP BC re: CHF issues phone extension 9739  or pager #9739 
 Cardiologist Follow Up Appointment:_______________________________________________________ 
 Primary Care Physician Follow Up Appointment:_____________________________________________ 
CAH - HEART FAILURE ROUTINE TELEPHONE CALL 
 
Telephone Assessment 
MANAGEMENT RECOMMENDATIONS / Follow-Up (check all that apply) 
 
 Figure 9.   Critical Access HF Routine Telephone Call 
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 Base Case Conservative Quoted in Literature 
DM Program $750 $1400 $93 - 1400 
HF Hospitalization $5000 $2500 $2500-14000 
Annual Outpatient 
HF Care 
$1700 $2700 $680-2700 
Annual Non-HF 
Health Care 
$10000 $13000 $7300-13000 
Figure 10.  Chan and colleagues (2008):  Cost Estimates for HFDM Program 
A cost-effectiveness analysis (CEA) was performed by Chan and colleagues for disease 
management programs enrolling high-risk to baseline-risk patients; standardized to 2005 US 
dollars by the consumer price index for health care.  Costs for hospitalization were incurred 
whenever a patient was hospitalized; also accounted for were yearly outpatient HF costs and 
non-HF health care costs (Chan et al., 2008).   
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Reference:   
United States National Library of Medicine: National Institutes of Health (n.d.). National Information Center on health Services 
Research and Health Care Technology (NICHSR). HTA 101: IV. Cost Analysis Methods. Retrieved on 11/17/2010 from 
http://www.nlm.nih.gov/nichsr/hta101/ta10106.html 
 
Figure 11.  Cost-Effective Analysis (CEA) 
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Appendix A 
 
Existing research on Heart Failure (HF) and Disease Management (DM) 
Citation Sample and 
location 
research/study 
was 
performed 
Design Outcomes/Results 
of the 
intervention 
and/or objectives 
of the study 
Strength(s) 
and 
weakness(es)  
Evidence 
 
Level    Class                 
Inglis et al.,  
(2010) 
25 full peer-
reviewed 
studies meta-
analysed. 
 
International 
 
Systematic 
Review and 
meta-
analysis 
Assess the effects 
of telemonitoring 
and/or structured 
telephone support 
programs on: 1. 
All-cause 
mortality, HF-
related admissions, 
all cause 
readmissions and; 
2.  Length of stay, 
QOL, healthcare 
cost savings in 
patients with HF 
and acceptability 
of the intervention 
to patients with 
HF. 
Strength of this 
review and 
meta-analysis is 
that these 
researchers 
considered and 
synthesized 
evidence on 
almost all 
aspects from 
which an effect 
of these 
interventions is 
important 
(mortality, 
hospitalizations, 
length of stay, 
acceptability, 
functional 
capacity and 
cost). 
 
Weakness: 
Unable to 
stratify results 
according to 
age, functional 
class or sex as 
outcomes were 
not reported in a 
manner that 
allowed 
extraction of 
sub-group 
specific data.  
  
 I 
 
  I 
Copeland, 
Berg, & 
Johnson 
(2010) 
458 pts 
 
South West, 
USA 
Prospective 
randomized 
controlled 
design with a 
1-year pre-
intervention 
data 
collection 
No differences in 
clinical outcomes 
were noted 
between the 
intervention group 
(telemedicine 
intervention) and 
the control group.  
Strength:  
RCT with a 1-
year pre-
intervention 
data collection 
period and a 1-
yr intervention 
and follow-up 
 
II 
 
 
IIa 
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period and a 
1-year 
intervention 
and follow-
up period. 
The HF related 
costs were higher 
for the intervention 
group, as were 
overall costs that 
included the cost 
of the intervention.  
Intervention group 
patients reported 
better compliance 
with weight 
monitoring and 
exercise 
recommendations. 
 
period. 
 
Weakness:  
Intervention 
process 
measures and 
patient-level 
details on 
numbers of 
calls and alerts 
were 
unavailable for 
this study.  All, 
but 5 patients, 
were male. 
Results of this 
study may not 
be generalizable 
to non-VA 
populations.   
Taylor et al., 
(2009) 
 
 
 
Sixteen trials 
involving 
1,627 patients 
were included. 
Systematic 
Review 
Effectiveness of 
disease 
management 
interventions for 
patients with HF. 
 
Interventions were 
classified into 
three models.   
 
Data abstracted 
does not allow for 
firm 
recommendations 
for practice. 
Strength: 
Objectives and 
criteria for 
inclusion were 
clearly defined. 
 
Weakness: 
There was some 
overlap between 
models with 
some 
interventions 
being difficult 
to classify.  
  
 I 
 
  IIb 
Hebert et al., 
(Oct. 2008) 
Randomly 
assigned 406 
patients to 
usual care (203 
patients) or a 
nurse-led 
program (203 
patients) in 
which patients 
had 1 in-person 
visit with a 
trained nurse 
and periodic 
follow-up 
telephone calls 
over 12 
Randomized 
Control Trial 
(RCT) 
A nurse-led 
disease 
management 
program for 
patients with HF 
improved QOL at 
an expected cost to 
society of less than 
$2177 per patient 
were more than 
offset by reduced 
hospital costs of 
$2378 per patient, 
but higher costs for 
outpatient 
procedures, 
Strength: 
This is the first 
cost-
effectiveness 
analysis for 
nurse 
management of 
HF to include 
all 
recommended 
categories of 
cost. 
 
Weakness: 
Since the trial 
was conducted 
 
II 
 
IIb 
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months. 
 
Harlem, NY 
medications, and 
home health care 
prevented the 
intervention from 
being cost-saving 
over the 12-month 
study. 
in an ethnically 
diverse, inner-
city 
neighborhood, 
these results 
may not be 
generalized to 
other settings. 
Esposito et al. 
(2008) 
37,000 
beneficiaries in 
the Medicare 
fee-for service 
(FFS) program. 
 
Southern 
Florida 
Randomized, 
intent to treat 
design; 
over 18 
month 
period of 
program 
operations. 
The LifeMasters 
Supported 
SelfCare 
demonstration 
program provides 
primarily 
telephonic patient 
education and 
monitoring 
services. 
Over the first 18 
program months, 
average Medicare 
costs of the 
treatment group 
were nearly 10 
percent lower (p = 
0.008) than those 
of the control 
group among 
patients with HF 
residing in the 
LifeMasters 
redesign catchment 
area at enrollment. 
For Medicare fee-
for service (FFS) 
program, 
beneficiaries with 
HF who resided in 
high-cost South 
Florida counties, 
the program 
reduced Medicare 
expenditures by 
9.6%. 
Strength: Large 
sample size, 
clear display of 
statistical 
results. 
 
Weakness: 
Portions of their 
analysis 
included other 
conditions, 
although HF 
was extracted 
separately for 
examination. 
Only 35% had 
HF even though 
it was a primary 
target condition 
for the 
demonstration. 
 
II 
 
I 
Zile et al., 
(2008) 
70 patients, a 
subgroup 
analysis of the 
COMPASS-HF 
Trial (Bourge 
et al., (2008). 
 
Randomized 
Trial, 
Diastolic 
heart failure 
patients 
(DHF) 
 
DHF patients were 
randomized to 
implantable 
hemodynamic 
monitor (IHM) 
guided care 
(treatment) vs. 
Strength:  
Statistical 
results 
discussed and 
clearly 
displayed. 
 
 
II 
 
IIb 
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Minneapolis, 
Minnesota 
 
New York 
Heart 
Association 
(NYHA) 
class III or 
IV HF pt’s 
included. 
standard care 
(control) for 6 
months. 
 
Results 
demonstrated a 
20% 
nonsignificant 
reduction in the 
overall heart 
failure-related 
events (HFRE) 
rate in the 
treatment group (p 
= .66).   IHM-
guided care did not 
result in a 
statistically 
significant 
reduction in HFRE 
rate or reduction in 
relative risk of a 
HFRE in DHF 
pt’s. 
 
 
Weakness: 
The 
COMPASS-HF 
trial (Bourge et 
al., 2008) was 
not designed or 
powered with a 
sufficient 
number of DHF 
patients to 
statistically test 
the efficacy of 
IHM-guided 
management in 
DHF patients as 
a separate 
group. 
Krantz et al., 
(2008) 
64 patients 
 
Denver, CO 
Randomized 
Control Trial 
Study compared 6-
month 
rehospitalization 
rates among 
patients assigned 
to predischarge B-
blockade coupled 
with postdischarge 
nurse management 
(intervention) 
versus usual care 
(control). 
 
Among 
intervention 
patients at 6-
months, B-blocker 
utilization was 
higher (p <.001), 
mean NYHA class 
improved (p=.01), 
and total HF 
rehospitalizations 
were reduced by 
84% (p = .02). A 
trend toward 
improved LVEF 
Strength: 
statistical 
results clearly 
displayed. 
Potential 
strengths of this 
intervention 
strategy include 
its simplicity 
and 
generalizability 
into a variety of 
patient 
populations and 
health systems. 
 
 
Weakness: 
Small sample 
size, vulnerable 
population , loss 
to follow-up, 
and single 
center 
experience in 
CO. 
 
II 
 
 I 
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was also observed 
(p = .17). 
Jaarsma et al., 
(2008) 
1023 patients 
 
Coordinating 
Study 
Evaluating 
Outcomes of 
Advising and 
Counseling in 
Heart Failure 
(COACH) 
 
Netherlands 
Randomized 
controlled 
trial 
 
NYHA 
functional 
class II to IV 
included. 
Pt’s were assigned 
after HF 
hospitalization to 1 
of 3 groups: 
control group (f/u 
by cardiologist) 
and 2 intervention 
groups with 
additional basic or 
intensive support 
by a nurse 
specializing in 
management of 
pt’s with HF.   
 
Primary findings 
do not support the 
concept that 
adding either a 
basic or an 
intensive nurse-led 
management 
program to 
standard care of a 
cardiologist 
reduces the 
combined end 
point of death or 
rehospitalization 
because of HF. 
 
Strength: 
Baseline 
characteristics 
of the 3 groups 
were 
comparable. 
Large sample 
size. 
 
Weakness: 
Limitations 
were not clearly 
stated. 
 
Explanations 
for the absence 
of a difference 
in the event rate 
between the 
control and 
intervention 
groups are that 
either patients 
in the control 
group were 
managed well 
enough already, 
thus making it 
difficult to 
further improve 
outcomes, or 
the quality of 
the intervention 
did not improve 
treatment. 
 
II 
 
IIb 
Ramachandran 
et al., (2007) 
50 patients: 2 
groups of 25 
pt’s each. 
 
India 
 
 
Prospective, 
Randomized 
clinical trial 
 
 
Two groups of 25 
pt’s each over six 
month study 
period.  The 
control group was 
managed in the HF 
clinic receiving 
usual care, and the 
intervention group 
underwent 
additional 
interventions 
utilizing 
interactive sessions 
Strength:  First 
report of the 
impact of a 
comprehensive 
telephone-based 
HF 
management 
program in 
India. 
 
Weakness: 
Small sample 
over short 
period: 6 mths.  
 
II 
 
IIa 
TRANSITIONS HOME FOR PATIENTS WITH HEART FAILURE  105 
and telephonic 
helpline telephone 
calls. 
 
 
There was 
significant 
improvement in 
the QOL and 
functional capacity 
of patients in the 
intervention group 
compared with 
controls over a 6-
mth period. 
Design and 
setting was 
specific to the 
needs of an 
Indian 
population.  
Limitations to 
the study were 
not discussed. 
Nguyen et al., 
(2007) 
 
 
190 patients: 
94 in the 
experimental 
group (HF 
management 
program) and 
96 in the 
control group 
(standard care). 
 
Montreal, 
Canada 
Randomized 
Trial 
Assessed long-
term recurrent ED 
visits, 
readmissions, and 
mortality among 
HF patients who 
were discharged 
after a 6-month 
intensive HF 
management 
program (HFMP). 
 
Study revealed no 
sustained long-
term benefit 
compared to usual 
care for severely ill 
patients (mostly 
NYHA III and IV) 
who have just been 
discharged from a 
successful 6-mth 
intensive HFDM 
program 
Strength: 
Despite small 
sample, ability 
to detect 
difference and 
large effect was 
good, because 
of the frequent 
occurrence of 
the outcome of 
interest. 
 
Weakness: 
Small sample 
size limits 
precision; lack 
of subgroup 
analyses. 
Unable to 
control for 
patient or 
physician 
variations. 
Subject with 
NYHA class II-
IV only. 
 
II 
 
III 
Del Sindaco et 
al.,  (2007) 
173 patients 
 
Italy 
Randomized 
Trial 
 
NYHA 
functional 
class III-IV 
included 
Aim of the study 
was to determine 
the long-term 
efficacy of a 
hybrid disease 
management 
program (DMP)  
involving 
interdisciplinary 
DM with 
Strength: 
Baseline 
evaluation upon 
discharge from 
hospital was 
discussed.   
 
 
 
Weakness: 
 
II 
 
IIa 
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cardiologists, 
PCPs, nurses 
(intervention 
group) and usual 
care (control 
group) who 
received all 
treatments and 
services ordered 
by ther PCPs and 
/or cardiologists; 
combining pre- 
and post-discharge 
care and following 
patients for 2 
years.  
 
At a 2-year follow-
up, a 36% 
reduction in all-
cause death and 
HF hospital 
admissions was 
observed in DMP 
vs. usual care.  
All-cause and HF 
admissions as well 
as length of 
hospital stay were 
also reduced.  This 
study 
demonstrated a 
hybrid DMP for 
elderly HF pt’s  
improves 
outcomes and is 
cost-effective over 
a long-term 
follow-up. 
Small sample; 
Study was 
conducted at 
specialized HF 
clinics, thus 
generalizability 
of findings to 
less specialized 
clinical settings 
remains 
unknown. 
Gohler et al., 
(2006) 
36 RCT studies 
published 
between 1993 
and 2005 from 
13 different 
countries with 
data from 8341 
patients. 
 
 
Boston, MA 
Berlin, 
Systematic 
Meta-
analysis 
A meta-analysis 
was performed to 
systematically 
combine the 
evidence on the 
efficacy of DMPs 
in the treatment of 
HF. 
Findings suggest 
that DMPs reduce 
all-cause mortality 
as well as first and 
Strength: 
Analysis was 
based on a 
larger sample 
size and 
therefore yields 
a more precise 
estimate. 
 
Weakness: 
Because of the 
nature of 
 
I 
 
I 
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Germany 
Hall, Austria 
subsequent 
hospitalizations in 
patients with HF. 
This meta-analysis 
yielded a pooled 
risk difference of 
3% (p < .01) for 
mortality and of 
8% (p < .0001) for 
rehospitalization, 
both favoring 
DMP. 
DMPs, blinding 
of patients and 
care providers 
to the 
intervention is 
not possible.  
Second, 
heterogeneity 
among included 
studies could 
only partly be 
explained by 
covariates.  
Also, 
intervention 
features vary 
from one DMP 
to another. 
Nucifora et al., 
(2006) 
200 HF 
patients. 
 
Italy 
RCT Randomized trial 
of 200 HF pt’s 
discharged from 
the hospital to 
evaluate the effect 
on re-
hospitalization and 
death of a 
comprehensive HF 
management 
program. 
 
Analysis suggests 
that the 
intervention group 
(intensive 
education by an 
experienced 
cardiovascular 
research nurse) did 
not achieve better 
results than the 
usual care control 
group who 
received the 
preexisting routine 
of post-discharge 
care. 
Strength: 
Patients were 
randomized 
during 
hospitalization, 
prior to 
discharge. 
 
 
Weakness: 
Small sample 
size.  Italian HF 
management 
guidelines from 
1998 were 
followed.  
 
II 
 
III 
Riegel et al., 
(2006) 
 
134 
hospitalized 
Hispanics with 
HF 
 
RCT Hospitalized 
Hispanics with 
chronic HF were 
enrolled and 
randomized to 
Strength: 
The 
intervention 
was refined to 
be culturally 
 
II 
 
III 
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U-Penn 
Philadelphia, 
PA; San Diego, 
CA 
intervention 
(telephone case 
management) or 
usual care 
(discharge 
instructions 
provided). 
 
No significant 
group differences 
were found in HF 
hospitalizations, 
HF readmission 
rate, HF days in 
the hospital, HF 
cost of care, all-
cause acute care 
use or cost, 
mortality, health-
related quality of 
life, or depression. 
appropriate. 
 
Weakness:  
Small sample 
size; 
Focused solely 
on Hispanics 
with HF 
pointing to a 
selective 
population 
group. 
Yu et al., 
(2006) 
Twenty-one 
RCTs 
published 
between 1995-
2004 
 
Studies 
originated in 
eight countries 
(Australia, 
Canada, 
Ireland, 
Netherlands, 
Spain, Sweden, 
UK, and USA). 
Systematic 
Review 
Twenty one trials 
were identified 
which reported 
disease 
management 
programs (DMPs) 
improving the 
discharge 
outcomes of older 
people with heart 
failure.   
Results indicate 
that an effective 
DMP should be 
multi-faceted and 
consist of an in-
hospital phase of 
care, intensive 
patient education, 
exercise and 
psychosocial 
counseling, self-
care supportive 
strategy, 
optimization of 
medical regimen, 
and ongoing 
surveillance and 
management of 
clinical 
Strenth: 
This review 
only included 
studies that 
randomized the 
sample and 
recruited a 
control group. 
 
Weakness: 
Sample size 
varied 
considerably 
among the 
studies; 
studies 
evaluated dates 
back to 1995; 
considerable 
variations in 
clinical factors 
among the 21 
reviewed 
studies were 
noted with 
significant 
regional 
differences in 
patient 
demographics. 
 
I 
 
 
  I 
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deterioration. 
Delgado-
Passler & 
McCaffrey 
(2006) 
Five RCT 
studies 
examined 
Literature 
Review 
The primary 
purpose of this 
literature review 
was to examine 
advanced practice 
nurse (APN)- 
directed versus 
registered nurse 
(RN)-directed 
telemanagement 
programs for heart 
failure.  
Findings from 
three RCT studies 
confirmed an APN 
role as effective in 
improving patient 
outcomes in HF 
management and 
reduce rates of 
readmissions. 
Strength: 
Study results 
were clearly 
displayed. 
 
Weakness: 
Studies were 
not meta-
analyzed.  
Outcome 
measures varied 
between all five 
studies. 
 
 IIa 
 
V 
Roccaforte et 
al. (2005) 
Thirty-three 
RCTs were 
included. 
Date ranges: 
1980-2004 
 
Canada & Italy 
 
 
Meta-
analysis 
Aim was to 
summarize the 
evidence 
supporting DMP 
effectiveness in 
improving HF 
clinical outcomes.  
RCTs were 
included if: 
patients were 
enrolled with a 
diagnosis of HF, 
were followed in 
an outpatient 
setting; a 
comprehensive 
DMP was 
compared to usual 
care; all-cause 
mortality and/or 
(re)hospitalization 
rates, and HF-
related 
(re)hospitalization 
rates and/or HF-
related mortality, 
were the outcomes 
assessed. 
Results 
Strength: 
A sensitivity 
analysis was 
performed, 
stratifying trials 
for the quality 
components 
considered: if 
all of them were 
present in a 
study, the study 
was deemed of 
“high” quality; 
otherwise, it 
was judged as 
being “not 
high”.  The 
literature search 
was 
continuously 
updated while 
the review was 
in progress. 
 
Weakness: 
It was not 
possible to 
demonstrate 
whether DM 
 
I 
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demonstrated that 
DMP reduced 
mortality and 
hospitalizations in 
HF patients.  
Because various 
types of DMP 
appear to be 
similarly effective, 
the choice of a 
specific program 
depends on local 
health services 
characteristics, 
patient population, 
and resources 
available. 
programs for 
HF were 
effective in all 
clinical settings, 
because most 
studies included 
were performed 
in academic, 
tertiary, or 
urban hospital 
centers. 
Phillips et al., 
(2005) 
Seven reports 
of six 
randomized 
clinical trials 
selected. 
Date ranges: 
1966-2004 
 
 
Boston & 
Baltimore, 
USA 
 
The 
Netherlands 
Meta-
regression 
analysis 
Objectives of this 
study were to 
determine whether 
a hierarchy of 
effectiveness exists 
with respect to 
complexity of 
published 
protocols of HF 
disease 
management (DM) 
incorporating 
specialist nurse-led 
HF clinics. 
The available 
evidence suggests 
that specialist 
nurse-led HF 
clinics are efficient 
additions to, or 
promising 
alternatives for, 
HF DM and a very 
appealing strategy 
for carefully 
selected patients. 
Strength: 
Data synthesis 
and results was 
well described. 
 
Weakness: 
The results 
reflect data 
from a limited 
number of 
studies that 
were not 
powered to 
detect changes 
in the range of 
outcomes 
evaluated; 
therefore, the 
possibility of a 
Type II error 
cannot be ruled 
out. 
 
I 
  
  I 
Ojeda et al., 
(2005) 
153 pt’s  
discharged 
from a 
Cardiology 
ward – Spain. 
 
 
 
RCT, 
Prospective 
study 
 
 
 
 
 
 The objective of 
the study was to 
evaluate whether 
improvements 
obtained during an 
HF intervention 
program were 
maintained after 
Strength: 
Statistical 
results were 
well displayed 
and discussed in 
detail.   Both 
groups were 
homogeneous in 
 
II 
 
  IIa 
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the program 
stopped.   
Patients were 
randomized to 
either usual care 
(control group) or 
the intervention 
group which 
consisted of formal 
education for 
patients and their 
families prior to 
discharge; self-
monitoring of vital 
signs, diet and 
exercise 
counseling, effects 
of medications, 
and measures to be 
taken in case of 
worsening.  After 
DC, regular f/u 
visits at the 
outpatient HF 
clinic were 
scheduled every 3 
months, to assess 
the pt’s knowledge 
of care, to 
optimize medical 
therapy and to 
reinforce the pt’s 
self-care.  Results 
demonstrated the 
positive effects of 
an intervention 
program are 
clearly reduced 
when it is stopped. 
terms of 
prevalence of 
cardiovascular 
risk factors.  
Etiology of HF 
was similar in 
control and 
intervention 
pt’s. 
 
Weakness: 
It is possible 
that these 
results cannot 
be extrapolated 
to all HF pt’s, 
since the study 
only included 
pt’s DC from 
the cardiology 
service; 
therefore, 
extrapolation of 
these results to 
a general 
population of 
pt’s with HF 
requires further 
study.  In 
addition, 
randomization 
of pt’s to either 
continuation or 
withdrawal of 
the program, 
was not done in 
this study. 
Source of applying classification of recommendations: 
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Oates, J. A., et 
al. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and 
Management of Heart Failure in Adults: A Report of the American College of Cardiology 
Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collarboration 
With the International Society for Heart and Lung Transplantaion. (DOI: 
10.1161/CIRCULATIONAHA.109.192065). Retrieved from American Heart Association: 
http://www.circ.ahajournals.org 
 
Source for applying level of evidence: 
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Melnyk, B., & Fineout-Overholt, E. (2005). Making the Case for Evidence-Based 
Practice. In Evidence-Based Practice in Nursing & Healthcare: A Guide to Best Practice (pp. 3-
24). Philadelphia: Lippincott Williams & Wilkins. 
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Appendix B 
Proposed Inputs and Outputs to the Organizational HF Pilot Proposal 
Elements Measure of Inputs Measure of Outputs Cost 
Human Resources: 
Quantity and quality of 
personnel: Personnel costs 
(New hires, FTEs, hours of 
training and education, 
biostatistial consulting). 
1. There were no new 
hires for this pilot 
program. 
2. Designated HF Nurse 
on 2MS/CCU will notify 
outpt cardiology to 
schedule appointment for 
HF pt’s with NP, prior to 
HF pt’s discharge. 
3.  Outpt cardiology 
receptionist will provide 
appointment to 
2MS/CCU HF nurse or 
charge nurse prior to pt. 
discharge. 
4. U-Mass biostatistical 
consulting 
1. No new employees  
 
 
2. Number of hours 
worked was not 
increased due to 
scheduling appt. for HF 
patients. 
 
3. Providing appt. 
day/time is existing 
responsibility of 
cardiology receptionist 
 
4.Biostatitical 
consulting fee at a 
student rate. 
During pilot – 
$60.00/hr student 
fee for UMass 
statistician 
 
After Pilot 
Completion: 
Program adoption 
may lead to hiring a 
designated 
cardiology NP.  
Estimated salary 
with total 
compensation 
(includes benefit 
package) est. 
$117,985.92 
Informational Resources: 
Computer hardware and 
software – a physical source; 
Information  
Systems (IS) computer 
generated reports. 
1.  During “pilot 
program” no upgrading of 
hardware or software 
occurred.   
2.  Printing materials for 
medical records and or 
documents  
3. New IS report 
capacities may occur after 
completion with 
information systems (IS) 
support. 
1.  Printing of 
tools/forms are 
anticipated for data 
collection purposes:  
Discharge Time Out & 
Post-discharge phone 
follow-up. 
2.  After completion of 
Pilot Program, adoption 
may lead into new 
report generation or 
electronic medical 
record specific for HF 
care.  
During pilot –  
$5.70 for two 
reams of paper. 
     
After Pilot 
Completion: 
Program adoption 
may lead into new 
report generation.  
Cost currently 
undetermined. 
Monetary Resources: 
Funding 
Amount of grant monies 
submitted for program 
funding. 
Awaiting determination  No funding or 
receipt of grant 
monies occurred  
Physical Resources: 
Material resources, facilities, 
and equipment.   
1.  No new equipment or 
facility space was 
anticipated for Pilot 
Program. 
2. Program adoption may 
require additional space 
for NP, if hired. 
1. No changes to 
physical resources are 
needed for HF Pilot 
Program intervention 
delivery. 
2. Program adoption 
may require 
additional exam room 
During pilot – 
$00.00 
 
Program adoption 
may require 
additional 
office/exam room 
space.  Cost 
currently 
undetermined.   
Managerial Resources: 
Program Manager/Facilitator 
1.  Education of program 
manager and/or facilitator 
1. No additional 
managers are 
Program facilitator 
estimated volunteer 
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is suitable for pilot;   
Program facilitator is a 
Doctor of Nursing 
Practice (DNPc) 
candidate in the Family 
Nurse Practitioner Track 
(FNPc). 
2. Additional assistance 
and coverage for 
facilitator provided by 
an RN; cardio-pulm 
dept. 
anticipated. 
2. Cardio-Pulm RN 
assisted facilitator 
with inpatient aspects 
along with f/u phone 
calls post discharge. 
 
hours per week:  
24-32 hours. 
This is “in-kind”, 
contributed time. 
Calculation to be 
determined by 
program mentor 
and CFO. 
 
Assistance from 
cardio-pulm RN 
was less than 8 hrs 
per week for pilot 
program with no 
additional cost.  
However, if 
program is adopted, 
designated staff 
would need to be 
established. 
Time Resources: 1.Timeline developed, 
presence of deadline for 
completion available  
1.No delay in meeting 
deadlines 
During pilot – 
$00.00 
TOTAL COSTS ANTICIPATED FOR PILOT PROGRAM 
 
TOTAL COST ANTICIPATED FOR  STATISTICAL CONSULTATION 
$5.70 +  
(in-kind amount) 
 
Student fee rate of 
$60.00 / hr. 
TOTAL COSTS FOR  THREE MONTH PILOT PROGRAM  
 
= $185.00 
(plus in-kind) 
TOTAL COST ANTICIPATED FOR  STATISTICAL CONSULTATION  
(with Pilot continuation, post doctoral) 
 
CARDIO-PULM. RN; increase of 8 hrs per week with pilot continuation. 
(Average RN hourly wage: $31.35/hr) 
                                                                  Pilot Continuation for 3 additional mths = 
$60-$80 per hour 
3 hrs anticipated 
$2,880. (3 mths) 
 
Estimated: 
$3,120. 
TOTAL COSTS ANTICIPATED FOR  PROGRAM ADOPTION $117,985.92 for 
hiring of new NP 
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Appendix C 
Proposed Inputs and Outputs to the Service Utilization Plan 
Elements Measure of Inputs Measure of 
Outputs 
Cost 
Recipients: 
Determines the extent to 
which the target audience 
has been reached. 
1. All HF patients who 
were discharged home 
were included in this 
pilot study. 
 2. HF patients being 
discharged to extended 
care facilities were 
excluded from this 
pilot study. 
3. HF patients who are 
transferred to another 
acute care center were 
excluded from this 
pilot study (1 pt. was 
waived). 
A. Extent to which 
the target audience 
has been reached. 
 
 
During pilot – 
$00.00 
Participants: 
Extent of multidisciplinary 
staff engagement. 
1. Hospitalists 
involvement was 
critical 
2. Nurses who will 
volunteer in becoming 
“HF Nurses” and/or 
champions for pilot 
program was critical. 
3. Cardiologist 
involvement was 
critical. 
4. Cardiology NP, 
involvement during 
outpatient HF patient 
visits was critical. 
A. Extent to which 
the target audiences 
has been reached. 
 
 
During pilot – 
$00.00 
 
Program adoption may 
require additional 
workshops for nurses 
focusing on acute HF 
care.    Cost currently 
undetermined.   
 
Cardiology NP 
involvement may 
necessitate additional 
compensation.  
Amount undetermined. 
Queuing: 
Ability of system to move 
patients through program 
 
1. Follow-up phone 
calls made post 
discharge within 24-48 
hours. 
 
2. Out pt. appointment 
with cardiology is 
scheduled 7-10 days 
post discharge 
1.  Data collection 
completed for f/u 
phone calls. 
 
 
2.  Patients are seen 
within 7-10 days in 
outpatient 
cardiology.   
During pilot -  
$00.00 
 
Social Marketing: 
Extent of social marketing 
1. Quality and extent 
of social marketing 
1.  Multi-
disciplinary team 
During pilot -  
$00.00 
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analysis 
 
within the 
organization will be 
conducted and 
maintained by the 
program facilitator. 
2. Meeting with local 
PCPs will be 
conducted through the 
CAH Medical Staff 
Dept. 
members at the CAH 
are aware of pilot 
program. 
2.  Pertinent Council 
and/or committee 
awareness occurred 
in Dec 2010 and Jan 
2011. 
3. PCPs in the region 
were informed of 
this pilot program 
and ensured their 
patients will 
continue to follow-
up with them for 
continuity in care. 
 
Program adoption may 
require additional 
marketing costs – 
currently 
undetermined. 
Intervention: 
How well the intervention 
was delivered to HF 
patients – Consistency of 
implementing program 
1. Multi-disciplinary 
staff were encouraged 
to be supportive of 
program interventions 
2.  Extent of revisions 
based on previous 
cycle or month of 
intervention delivery. 
1.  Number of hours 
for program delivery 
will be tracked  
2.  Number of 
participants 
completing 
intervention (service 
completion) will be 
tracked.  
 
See Table for cost 
benefit analysis 
Organization: 
How well this pilot was 
viewed by stakeholders 
and staff. 
1. Viewpoints and 
participation of 
administration 
1. Viewpoints and 
participation of 
hospitalists and 
cardiologists 
2. Viewpoints and 
participation of 
nursing staff 
1.Administration 
acceptance 
2. Hospitalists 
acceptance 
3. Nursing staff 
acceptance 
During pilot – 
Est. $00.00 
TOTAL COSTS ANTICIPATED FOR PILOT PROGRAM $00.00 
TOTAL COSTS ANTICIPATED FOR  PROGRAM ADOPTION Undetermined 
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